{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:32:40Z","timestamp":1790609560916,"version":"4.1.0"},"reference-count":412,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union Horizon 2020","award":["825828"],"award-info":[{"award-number":["825828"]}]},{"name":"National Research, Development, and Innovation Office (NKFIH) of Hungary","award":["2020-1.1.6-J\u00f6v\u00f6"],"award-info":[{"award-number":["2020-1.1.6-J\u00f6v\u00f6"]}]},{"name":"National Research, Development, and Innovation Office (NKFIH) of Hungary","award":["2021-00013"],"award-info":[{"award-number":["2021-00013"]}]},{"name":"National Research, Development, and Innovation Office (NKFIH) of Hungary","award":["2022-1.2.5-T\u00c9T-IPARI-KR-2022-00009"],"award-info":[{"award-number":["2022-1.2.5-T\u00c9T-IPARI-KR-2022-00009"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>A reassessment of the risk-benefit balance of the two lipid nanoparticle (LNP)-based vaccines, Pfizer\u2019s Comirnaty and Moderna\u2019s Spikevax, is currently underway. While the FDA has approved updated products, their administration is recommended only for individuals aged 65 years or older and for those aged 6 months or older who have at least one underlying medical condition associated with an increased risk of severe COVID-19. Among other factors, this change in guidelines reflect an expanded spectrum and increased incidence of adverse events (AEs) and complications relative to other vaccines. Although severe AEs are relatively rare (occurring in &lt;0.5%) in vaccinated individuals, the sheer scale of global vaccination has resulted in millions of vaccine injuries, rendering post-vaccination syndrome (PVS) both clinically significant and scientifically intriguing. Nevertheless, the cellular and molecular mechanisms of these AEs are poorly understood. To better understand the phenomenon and to identify research needs, this review aims to highlight some theoretically plausible connections between the manifestations of PVS and some unique structural properties of mRNA-LNPs. The latter include (i) ribosomal synthesis of the antigenic spike protein (SP) without natural control over mRNA translation, diversifying antigen processing and presentation; (ii) stabilization of the mRNA by multiple chemical modification, abnormally increasing translation efficiency and frameshift mutation risk; (iii) encoding for SP, a protein with multiple toxic effects; (iv) promotion of innate immune activation and mRNA transfection in off-target tissues by the LNP, leading to systemic inflammation with autoimmune phenomena; (v) short post-reconstitution stability of vaccine nanoparticles contributing to whole-body distribution and mRNA transfection; (vi) immune reactivity and immunogenicity of PEG on the LNP surface increasing the risk of complement activation with LNP disintegration and anaphylaxis; (vii) GC enrichment and double proline modifications stabilize SP mRNA and prefusion SP, respectively; and (viii) contaminations with plasmid DNA and other organic and inorganic elements entailing toxicity with cancer risk. The collateral immune anomalies considered are innate immune activation, T-cell- and antibody-mediated cytotoxicities, dissemination of pseudo virus-like hybrid exosomes, somatic hypermutation, insertion mutagenesis, frameshift mutation, and reverse transcription. Lessons from mRNA-LNP vaccine-associated AEs may guide strategies for the prediction, prevention, and treatment of AEs, while informing the design of safer next-generation mRNA vaccines and therapeutics.<\/jats:p>","DOI":"10.3390\/pharmaceutics17101327","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:13:27Z","timestamp":1760361207000},"page":"1327","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Unique Features and Collateral Immune Effects of mRNA-LNP COVID-19 Vaccines: Plausible Mechanisms of Adverse Events and Complications"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1738-797X","authenticated-orcid":false,"given":"J\u00e1nos","family":"Szebeni","sequence":"first","affiliation":[{"name":"Nanomedicine Research and Education Center, Department of Translational Medicine, Semmelweis University, 1085 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"ref_1","unstructured":"(2025, September 22). Center of Disease Control and Prevention (CDC): Our World in Data. Available online: https:\/\/ourworldindata.org\/grapher\/covid-vaccine-doses-by-manufacturer?country=European+Union~HUN~USA."},{"key":"ref_2","first-page":"1","article-title":"Post-Vaccination Syndrome: A Descriptive Analysis of Reported Symptoms and Patient Experiences after COVID-19 Immunization","volume":"10","author":"Krumholz","year":"2023","journal-title":"medRxiv"},{"key":"ref_3","unstructured":"Palmer, M., Bhakdi, S., Hooker, B., Holland, M., DesBois, M., Rasnick, D., and Fitts, C.A. (2025, September 22). mRNA Vaccine Toxicity. D4ce.Org. Available online: https:\/\/d4ce.org\/mRNA-vaccine-toxicity\/."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4470326","DOI":"10.1155\/2024\/4470326","article-title":"The Epidemiology of COVID-19 Vaccine-Induced Myocarditis","volume":"2024","author":"Costa","year":"2024","journal-title":"Adv. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1080\/08830185.2021.1939696","article-title":"Adverse Rare Events to Vaccines for COVID-19: From Hypersensitivity Reactions to Thrombosis and Thrombocytopenia","volume":"41","author":"Novak","year":"2022","journal-title":"Int. Rev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Oueijan, R.I., Hill, O.R., Ahiawodzi, P.D., Fasinu, P.S., and Thompson, D.K. (2022). Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review. Medicines, 9.","DOI":"10.3390\/medicines9080043"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e1224","DOI":"10.1002\/prp2.1224","article-title":"Incidence and Management of the Main Serious Adverse Events Reported after COVID-19 Vaccination","volume":"12","author":"Sampieri","year":"2024","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_8","unstructured":"Law, B. (2025, September 22). Priority List of COVID-19 Adverse Events of Special Interest: Quarterly Update December 2020. Safety Platform for Emergency Vaccines (SPEAC). Available online: https:\/\/brightoncollaboration.org\/wp-content\/uploads\/2023\/08\/SO2_D2.1.2_V1.2_COVID-19_AESI-update_V1.3-1.pdf."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1016\/j.vaccine.2022.08.036","article-title":"Serious Adverse Events of Special Interest Following mRNA COVID-19 Vaccination in Randomized Trials in Adults","volume":"40","author":"Fraiman","year":"2022","journal-title":"Vaccine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.vaccine.2024.01.100","article-title":"COVID-19 Vaccines and Adverse Events of Special Interest: A Multinational Global Vaccine Data Network (GVDN) Cohort Study of 99 Million Vaccinated Individuals","volume":"42","author":"Faksova","year":"2024","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Slater, K.M., Buttery, J.P., Crawford, N.W., and Cheng, D.R. (2024). Letter to the Editor: A Comparison of Post-COVID Vaccine Myocarditis Classification Using the Brighton Collaboration Criteria Versus (United States) Centers for Disease Control Criteria: An Update. Commun. Dis. Intell., 48.","DOI":"10.33321\/cdi.2024.48.18"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.vaccine.2023.09.039","article-title":"The Brighton Collaboration Standardized Module for Vaccine Benefit-Risk Assessment","volume":"42","author":"Levitan","year":"2024","journal-title":"Vaccine"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Szebeni, J. (2025). Expanded Spectrum and Increased Incidence of Adverse Events Linked to COVID-19 Genetic Vaccines: New Concepts on Prophylactic Immuno-Gene Therapy, Iatrogenic Orphan Disease, and Platform-Inherent Challenges. Pharmaceutics, 17.","DOI":"10.20944\/preprints202411.1837.v3"},{"key":"ref_14","unstructured":"Sass, E. (2025). COVID-19 mRNA \u201cVaccine\u201d Harms Research Collection (Version 2). Toxic Shot: Facing the Dangers of the COVID \u201cVaccines\u201d, Zenodo."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"13147","DOI":"10.1021\/acsnano.2c11904","article-title":"Insights into the Structure of Comirnaty COVID-19 Vaccine: A Theory on Soft, Partially Bilayer-Covered Nanoparticles with Hydrogen Bond-Stabilized mRNA-Lipid Complexes","volume":"17","author":"Szebeni","year":"2023","journal-title":"ACS Nano"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","article-title":"Pathways of Antigen Processing","volume":"31","author":"Blum","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sarri, C.A., Papadopoulos, G.E., Papa, A., Tsakris, A., Pervanidou, D., Baka, A., Politis, C., Billinis, C., Hadjichristodoulou, C., and Malwest Project (2018). Amino Acid Signatures in the Hla Class Ii Peptide-Binding Region Associated with Protection\/Susceptibility to the Severe West Nile Virus Disease. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0205557"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nri3818","article-title":"The Ins and Outs of MHC Class Ii-Mediated Antigen Processing and Presentation","volume":"15","author":"Roche","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","article-title":"Lipofection: A Highly Efficient, Lipid-Mediated DNA-Transfection Procedure","volume":"84","author":"Felgner","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1073\/pnas.86.16.6077","article-title":"Cationic Liposome-Mediated Rna Transfection","volume":"86","author":"Malone","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","unstructured":"Holland, J.W., Madden, T.D., and Pieter, R.C. (1999). Bilayer Stabilizing Components and Their Use in Forming Programmable Fusogenic Liposomes."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ymeth.2003.11.023","article-title":"Advanced Transfection with Lipofectamine 2000 Reagent: Primary Neurons, Sirna, and High-Throughput Applications","volume":"33","author":"Dalby","year":"2004","journal-title":"Methods"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid Nanoparticle Systems for Enabling Gene Therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1021\/acsnano.8b01516","article-title":"On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and Sirna","volume":"12","author":"Kulkarni","year":"2018","journal-title":"ACS Nano"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro Story and the Clinical Translation of Nanomedicines Containing Nucleic Acid-Based Drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/s41578-021-00379-9","article-title":"From Lipids to Lipid Nanoparticles to mRNA Vaccines","volume":"6","author":"Horejs","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid Nanoparticles for mRNA Delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Pateev, I., Seregina, K., Ivanov, R., and Reshetnikov, V. (2023). Biodistribution of RNA Vaccines and of Their Products: Evidence from Human and Animal Studies. Biomedicines, 12.","DOI":"10.3390\/biomedicines12010059"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","article-title":"The 60-Year Evolution of Lipid Nanoparticles for Nucleic Acid Delivery","volume":"23","author":"Cullis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of Rna Recognition by Toll-Like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA","volume":"23","author":"Kariko","year":"2005","journal-title":"Immunity"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of Pseudouridine into mRNA Yields Superior Nonimmunogenic Vector with Increased Translational Capacity and Biological Stability","volume":"16","author":"Kariko","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1093\/nar\/gkq347","article-title":"Incorporation of Pseudouridine into mRNA Enhances Translation by Diminishing Pkr Activation","volume":"38","author":"Anderson","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1093\/nar\/gkr586","article-title":"Nucleoside Modifications in Rna Limit Activation of 2\u2032-5\u2032-Oligoadenylate Synthetase and Increase Resistance to Cleavage by Rnase L","volume":"39","author":"Anderson","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1093\/nar\/gkr695","article-title":"Generating the Optimal mRNA for Therapy: Hplc Purification Eliminates Immune Activation and Improves Translation of Nucleoside-Modified, Protein-Encoding mRNA","volume":"39","author":"Kariko","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-62703-260-5_2","article-title":"In Vitro Transcription of Long mRNA Containing Modified Nucleosides","volume":"969","author":"Pardi","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-Based Therapeutics--Developing a New Class of Drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1146\/annurev.immunol.24.021605.090542","article-title":"The Evolution of Adaptive Immunity","volume":"24","author":"Pancer","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nri2807","article-title":"The Origins of Vertebrate Adaptive Immunity","volume":"10","author":"Litman","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrg2703","article-title":"Origin and Evolution of the Adaptive Immune System: Genetic Events and Selective Pressures","volume":"11","author":"Flajnik","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA Vaccines for Infectious Diseases: Principles, Delivery and Clinical Translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","article-title":"Mechanisms of Innate and Adaptive Immunity to the Pfizer-Biontech BNT 162b2 Vaccine","volume":"23","author":"Lee","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Embgenbroich, M., and Burgdorf, S. (2018). Current Concepts of Antigen Cross-Presentation. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01643"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nri3254","article-title":"Cross-Presentation by Dendritic Cells","volume":"12","author":"Joffre","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.immunol.19.1.47","article-title":"Cross-Presentation, Dendritic Cells, Tolerance and Immunity","volume":"19","author":"Heath","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"857143","DOI":"10.1155\/2014\/857143","article-title":"The Role of Dendritic Cells in Tissue-Specific Autoimmunity","volume":"2014","author":"Mbongue","year":"2014","journal-title":"J. Immunol. Res."},{"key":"ref_46","first-page":"172","article-title":"Cross-Presentation of Self Antigens to Cd8+ T Cells: The Balance between Tolerance and Autoimmunity","volume":"215","author":"Kurts","year":"1998","journal-title":"Novartis Found. Symp."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.it.2017.07.007","article-title":"Dendritic Cells as Inducers of Peripheral Tolerance","volume":"38","author":"Iberg","year":"2017","journal-title":"Trends Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Lang, S., Nguyen, D., Bhadra, P., Jung, M., Helms, V., and Zimmermann, R. (2022). Signal Peptide Features Determining the Substrate Specificities of Targeting and Translocation Components in Human ER Protein Import. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.833540"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1038\/s41467-025-57446-w","article-title":"Monitoring mRNA Vaccine Antigen Expression in Vivo Using Pet\/Ct","volume":"16","author":"Blizard","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Burkova, E.E., and Bakhno, I.A. (2025). Sequences in the Cytoplasmic Tail Contribute to the Intracellular Trafficking and the Cell Surface Localization of SARS-CoV-2 Spike Protein. Biomolecules, 15.","DOI":"10.3390\/biom15020280"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Yamamoto, Y., Inoue, T., Inoue, M., Murae, M., Fukasawa, M., Kaneko, M.K., Kato, Y., and Noguchi, K. (2022). SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1\/S2 Processing. Int. J. Mol. Sci., 23.","DOI":"10.20944\/preprints202210.0245.v1"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1038\/s41467-021-25589-1","article-title":"Sequences in the Cytoplasmic Tail of SARS-CoV-2 Spike Facilitate Expression at the Cell Surface and Syncytia Formation","volume":"12","author":"Welch","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Bakos, T., Meszaros, T., Kozma, G.T., Berenyi, P., Facsko, R., Farkas, H., Dezsi, L., Heirman, C., de Koker, S., and Schiffelers, R. (2024). mRNA-Lnp COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines: Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions. Int. J. Mol. Sci., 25.","DOI":"10.1101\/2024.01.12.575122"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"25254","DOI":"10.1073\/pnas.2010722117","article-title":"Superantigenic Character of an Insert Unique to SARS-CoV-2 Spike Supported by Skewed Tcr Repertoire in Patients with Hyperinflammation","volume":"117","author":"Cheng","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0092-8674(89)90980-X","article-title":"The V Beta-Specific Superantigen Staphylococcal Enterotoxin B: Stimulation of Mature T Cells and Clonal Deletion in Neonatal Mice","volume":"56","author":"White","year":"1989","journal-title":"Cell"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Rivas, N., Porritt, R.A., Cheng, M.H., Bahar, I., and Arditi, M. (2022). Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.941009"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1007\/s00431-024-05586-4","article-title":"Multisystemic Inflammatory Syndrome in Children and the Bnt162b2 Vaccine: A Nationwide Cohort Study","volume":"183","author":"Schwartz","year":"2024","journal-title":"Eur. J. Pediatr."},{"key":"ref_58","first-page":"18","article-title":"Multisystem Inflammatory Syndrome in Children (Mis-C): The Role of Viral Superantigens in COVID-19 Disease","volume":"1","author":"Bittmann","year":"2020","journal-title":"J. Allergy Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Hamdy, A., and Leonardi, A. (2022). Superantigens and SARS-CoV-2. Pathogens, 11.","DOI":"10.3390\/pathogens11040390"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41577-021-00502-5","article-title":"Super(Antigen) Target for SARS-CoV-2","volume":"21","author":"Matthew","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2666-5247(23)00144-1","article-title":"The SARS-CoV-2 Furin Cleavage Site: Natural Selection or Smoking Gun?","volume":"4","author":"Lubinski","year":"2023","journal-title":"Lancet Microbe"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"109997","DOI":"10.1016\/j.virol.2024.109997","article-title":"A Cell-Adapted SARS-CoV-2 Mutant, Showing a Deletion in the Spike Protein Spanning the Furin Cleavage Site, Has Reduced Virulence at the Lung Level in K18-Hace2 Mice","volume":"592","author":"Valleriani","year":"2024","journal-title":"Virology"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Li, L., Gao, M., Li, J., Xie, X., Zhao, H., Wang, Y., Xu, X., Zu, S., Chen, C., and Wan, D. (2023). Identification of an Immunogenic Epitope and Protective Antibody against the Furin Cleavage Site of SARS-CoV-2. EBioMedicine, 87.","DOI":"10.1016\/j.ebiom.2022.104401"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41590-020-0762-x","article-title":"Single-Cell Landscape of Immunological Responses in Patients with COVID-19","volume":"21","author":"Zhang","year":"2020","journal-title":"Nat. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"28336","DOI":"10.1073\/pnas.2018030117","article-title":"Transcriptional and Proteomic Insights into the Host Response in Fatal COVID-19 Cases","volume":"117","author":"Wu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Suzuki, Y.J., and Gychka, S.G. (2021). SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines. Vaccines, 9.","DOI":"10.3390\/vaccines9010036"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12969-023-00848-1","article-title":"The Protective Effect of COVID-19 Vaccines on Developing Multisystem Inflammatory Syndrome in Children (Mis-C): A Systematic Literature Review and Meta-Analysis","volume":"21","author":"Wulffraat","year":"2023","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3390\/vaccines11050956","article-title":"Multisystem Inflammatory Syndrome in Children (Mis-C), Possibly Due to COVID-19 mRNA Vaccination","volume":"11","author":"Alije","year":"2023","journal-title":"Vaccines"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.immunol.17.1.435","article-title":"The Structural Basis of T Cell Activation by Superantigens","volume":"17","author":"Li","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00431-021-03993-5","article-title":"Multisystem Inflammatory Syndrome in Children Related to COVID-19: A Systematic Review","volume":"180","author":"Hoste","year":"2021","journal-title":"Eur. J. Pediatr."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Ruvinsky, S., Voto, C., Roel, M., Fustinana, A., Veliz, N., Brizuela, M., Rodriguez, S., Ulloa-Gutierrez, R., and Bardach, A. (2022). Multisystem Inflammatory Syndrome Temporally Related to COVID-19 in Children from Latin America and the Caribbean Region: A Systematic Review with a Meta-Analysis of Data from Regional Surveillance Systems. Front. Pediatr., 10.","DOI":"10.3389\/fped.2022.881765"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"COVID-Investigators Overcoming, and CDC COVID- Response Team. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Lauster, D., Osterrieder, K., Haag, R., Ballauff, M., and Herrmann, A. (2023). Respiratory Viruses Interacting with Cells: The Importance of Electrostatics. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1169547"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"106230","DOI":"10.1016\/j.isci.2023.106230","article-title":"Evolution of Increased Positive Charge on the SARS-CoV-2 Spike Protein May Be Adaptation to Human Transmission","volume":"26","author":"Cotten","year":"2023","journal-title":"iScience"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"23283","DOI":"10.1021\/acsomega.3c00944","article-title":"Evolution of Sequence and Structure of SARS-CoV-2 Spike Protein: A Dynamic Perspective","volume":"8","author":"Sinha","year":"2023","journal-title":"ACS Omega"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Rafaniello, C., Gaio, M., Zinzi, A., Sullo, M.G., Liguori, V., Ferraro, M., Petronzelli, F., Felicetti, P., Marchione, P., and Marra, A.R. (2022). Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines. Pharmaceuticals, 15.","DOI":"10.3390\/ph15050525"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Massari, M., Alegiani, S.S., Morciano, C., Spuri, M., Marchione, P., Felicetti, P., Belleudi, V., Poggi, F.R., Lazzeretti, M., and Ercolanoni, M. (2022). Vax TheShin, and COVID Surveillance Group. Postmarketing Active Surveillance of Myocarditis and Pericarditis Following Vaccination with COVID-19 mRNA Vaccines in Persons Aged 12 to 39 Years in Italy: A Multi-Database, Self-Controlled Case Series Study. PLoS Med., 19.","DOI":"10.1101\/2022.02.07.22270020"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e1218","DOI":"10.1002\/prp2.1218","article-title":"Long-Lasting, Biochemically Modified mRNA, and Its Frameshifted Recombinant Spike Proteins in Human Tissues and Circulation after COVID-19 Vaccination","volume":"12","author":"Boros","year":"2024","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCULATIONAHA.122.061025","article-title":"Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis","volume":"147","author":"Yonker","year":"2023","journal-title":"Circulation"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Amormino, C., Tedeschi, V., Paldino, G., Arcieri, S., Fiorillo, M.T., Paiardini, A., Tuosto, L., and Kunkl, M. (2022). SARS-CoV-2 Spike Does Not Possess Intrinsic Superantigen-Like Inflammatory Activity. Cells, 11.","DOI":"10.3390\/cells11162526"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Paiardi, G., Richter, S., Oreste, P., Urbinati, C., Rusnati, M., and Wade, R.C. (2022). The Binding of Heparin to Spike Glycoprotein Inhibits SARS-CoV-2 Infection by Three Mechanisms. J. Biol. Chem., 298.","DOI":"10.1016\/j.jbc.2021.101507"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.str.2021.04.005","article-title":"A Monoclonal Antibody against Staphylococcal Enterotoxin B Superantigen Inhibits SARS-CoV-2 Entry in Vitro","volume":"29","author":"Cheng","year":"2021","journal-title":"Structure"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Dima, F., Salvagno, G.L., and Lippi, G. (2024). Effects of Recombinant SARS-CoV-2 Spike Protein Variants on Red Blood Cells Parameters and Red Blood Cell Distribution Width. Biomed. J., 47.","DOI":"10.1016\/j.bj.2024.100787"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Jung, F., and Connes, P. (2024). Morphology and Function of Red Blood Cells in COVID-19 Patients: Current Overview 2023. Life, 14.","DOI":"10.3390\/life14040460"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1111\/jcmm.17320","article-title":"Even Patients with Mild COVID-19 Symptoms after SARS-CoV-2 Infection Show Prolonged Altered Red Blood Cell Morphology and Rheological Parameters","volume":"26","author":"Grau","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Boschi, C., Scheim, D.E., Bancod, A., Militello, M., Bideau, M.L., Colson, P., Fantini, J., and Scola, B. (2022). SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects. Int. J. Mol. Sci., 23.","DOI":"10.1101\/2022.11.24.517882"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Scheim, D.E., Vottero, P., Santin, A.D., and Hirsh, A.G. (2023). Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242317039"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s11239-024-03008-8","article-title":"SARS-CoV-2 Spike Protein Potentiates Platelet Aggregation Via Upregulating Integrin Alphaiibbeta3 Outside-in Signaling Pathway","volume":"57","author":"Wang","year":"2024","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41467-023-36279-5","article-title":"Direct Cryo-Et Observation of Platelet Deformation Induced by SARS-CoV-2 Spike Protein","volume":"14","author":"Kuhn","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Luzak, B., Rozalski, M., Przygodzki, T., Boncler, M., Wojkowska, D., Kosmalski, M., and Watala, C. (2023). SARS-CoV-2 Spike Protein and Neutralizing Anti-Spike Protein Antibodies Modulate Blood Platelet Function. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065312"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Degenfeld-Schonburg, L., Sadovnik, I., Smiljkovic, D., Peter, B., Stefanzl, G., Gstoettner, C., Jaksch, P., Hoetzenecker, K., Aigner, C., and Radtke, C. (2024). Coronavirus Receptor Expression Profiles in Human Mast Cells, Basophils, and Eosinophils. Cells, 13.","DOI":"10.3390\/cells13020173"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12964-024-01718-3","article-title":"SARS-CoV-2-Associated Lymphopenia: Possible Mechanisms and the Role of Cd147","volume":"22","author":"Shouman","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_94","first-page":"11992","article-title":"Cd147 as an Alternative Binding Site for the Spike Protein on the Surface of SARS-CoV-2","volume":"24","author":"Faghihi","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","article-title":"Cd147-Spike Protein Is a Novel Route for SARS-CoV-2 Infection to Host Cells","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"152072","DOI":"10.1016\/j.scitotenv.2021.152072","article-title":"CD147-Spike Protein Interaction in COVID-19: Get the Ball Rolling with a Novel Receptor and Therapeutic Target","volume":"808","author":"Behl","year":"2022","journal-title":"Sci. Total Environ."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"132427","DOI":"10.1016\/j.snb.2022.132427","article-title":"Enhanced Susceptibility of SARS-CoV-2 Spike RBD Protein Assay Targeted by Cellular Receptors ACE2 and CD147: Multivariate Data Analysis of Multisystem Impedimetric Response","volume":"370","author":"Brodowski","year":"2022","journal-title":"Sens. Actuators B Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.56098\/16j4nf05","article-title":"Autoimmune and Neoplastic Outcomes After the mRNA Vaccination: The Role of T Regulatory Cell Responses","volume":"3","author":"Kyriakopoulos","year":"2024","journal-title":"Int. J. Vaccine Theory Pract. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"113008","DOI":"10.1016\/j.fct.2022.113008","article-title":"Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and microRNAs","volume":"164","author":"Seneff","year":"2022","journal-title":"Food Chem. Toxicol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.2100637","article-title":"Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT-162b2 (Pfizer-BioNtech) Vaccination Prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines","volume":"207","author":"Bansal","year":"2021","journal-title":"J. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Tsai, S.J., Atai, N.A., Cacciottolo, M., Nice, J., Salehi, A., Guo, C., Sedgwick, A., Kanagavelu, S., and Gould, S.J. (2021). Exosome-Mediated mRNA Delivery in Vivo Is Safe and Can Be Used to Induce SARS-CoV-2 Immunity. J. Biol. Chem., 297.","DOI":"10.1016\/j.jbc.2021.101266"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Cacciottolo, M., Nice, J.B., Li, Y., LeClaire, M.J., Twaddle, R., Mora, C.L., Adachi, S.Y., Chin, E.R., Young, M., and Angeles, J. (2023). Exosome-Based Multivalent Vaccine: Achieving Potent Immunization, Broadened Reactivity, and Strong T-Cell Responses with Nanograms of Proteins. Microbiol. Spectr., 11.","DOI":"10.1128\/spectrum.00503-23"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.4049\/jimmunol.2101067","article-title":"Response to Comment on \u201cCutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT-162b2 (Pfizer-Biontech) Vaccination Prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines\u201d","volume":"208","author":"Bansal","year":"2022","journal-title":"J. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Giannotta, G., Murrone, A., and Giannotta, N. (2023). COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events. Vaccines, 11.","DOI":"10.3390\/vaccines11040747"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Bellavite, P., Ferraresi, A., and Isidoro, C. (2023). Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020451"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-Modified mRNA Vaccines Induce Potent T Follicular Helper and Germinal Center B Cell Responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1172\/JCI78084","article-title":"Autoantibodies in Systemic Autoimmune Diseases: Specificity and Pathogenicity","volume":"125","author":"Suurmond","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Alriyami, M., and Polychronakos, C. (2021). Somatic Mutations and Autoimmunity. Cells, 10.","DOI":"10.3390\/cells10082056"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/08916930802629554","article-title":"Lupus-Prone Mrl\/Faslpr\/Lpr Mice Display Increased Aid Expression and Extensive DNA Lesions, Comprising Deletions and Insertions, in the Immunoglobulin Locus: Concurrent Upregulation of Somatic Hypermutation and Class Switch DNA Recombination","volume":"42","author":"Zan","year":"2009","journal-title":"Autoimmunity"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1084\/jem.20092712","article-title":"Somatic Hypermutation as a Generator of Antinuclear Antibodies in a Murine Model of Systemic Autoimmunity","volume":"207","author":"Guo","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-3083.2010.02405.x","article-title":"Analysis of Vh Gene Rearrangement and Somatic Hypermutation in Sjogren\u2019s Syndrome and Igg4-Related Sclerosing Sialadenitis","volume":"72","author":"Sakuma","year":"2010","journal-title":"Scand. J. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jaut.2010.07.004","article-title":"Somatic Hypermutation and Antigen-Driven Selection of B Cells Are Altered in Autoimmune Diseases","volume":"35","author":"Zuckerman","year":"2010","journal-title":"J. Autoimmun."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1440-1827.2012.02788.x","article-title":"Analysis of Vh Gene Rearrangement and Somatic Hypermutation in Type 1 Autoimmune Pancreatitis","volume":"62","author":"Okumura","year":"2012","journal-title":"Pathol. Int."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/08916934.2012.748751","article-title":"The Role of Somatic Hypermutation in the Generation of Pathogenic Antibodies in Sle","volume":"46","author":"Schroeder","year":"2013","journal-title":"Autoimmunity"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41586-023-06800-3","article-title":"N(1)-Methylpseudouridylation of mRNA Causes +1 Ribosomal Frameshifting","volume":"625","author":"Mulroney","year":"2024","journal-title":"Nature"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Safra, M., Tamari, Z., Polak, P., Shiber, S., Matan, M., Karameh, H., Helviz, Y., Levy-Barda, A., Yahalom, V., and Peretz, A. (2023). Altered Somatic Hypermutation Patterns in COVID-19 Patients Classifies Disease Severity. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1031914"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"109716","DOI":"10.1016\/j.isci.2024.109716","article-title":"B Cell Somatic Hypermutation Following COVID-19 Vaccination with Ad26.Cov2.S","volume":"27","author":"Lifton","year":"2024","journal-title":"iScience"},{"key":"ref_118","first-page":"e75652","article-title":"Behavioral and Health Outcomes of mRNA COVID-19 Vaccination: A Case-Control Study in Japanese Small and Medium-Sized Enterprises","volume":"16","author":"Nakatani","year":"2024","journal-title":"Cureus"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jmb.2017.05.017","article-title":"Rna G-Quadruplexes in Biology: Principles and Molecular Mechanisms","volume":"429","author":"Fay","year":"2017","journal-title":"J. Mol. Biol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e2105968118","DOI":"10.1073\/pnas.2105968118","article-title":"Reverse-Transcribed SARS-CoV-2 RNA Can Integrate into the Genome of Cultured Human Cells and Can Be Expressed in Patient-Derived Tissues","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/cimb44030073","article-title":"Intracellular Reverse Transcription of Pfizer Biontech COVID-19 mRNA Vaccine BNT-162b2 in Vitro in Human Liver Cell Line","volume":"44","author":"Alden","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"eabf1771","DOI":"10.1126\/sciadv.abf1771","article-title":"Poltheta Reverse Transcribes Rna and Promotes Rna-Templated DNA Repair","volume":"7","author":"Chandramouly","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_123","first-page":"eabf1771","article-title":"To Stabilize or Not to Stabilize RNA\u2014That Is Still the Question","volume":"7","author":"Boros","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Kruchinin, A.A., and Makarova, A.V. (2023). Multifaceted Nature of DNA Polymerase Theta. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043619"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1038\/s41467-019-12234-1","article-title":"Genetic Determinants of Cellular Addiction to DNA Polymerase Theta","volume":"10","author":"Feng","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_126","first-page":"1","article-title":"Potential Mechanisms for Human Genome Integration of Genetic Code from SARS-CoV-2 mRNA Vaccination Potential Mechanisms for Human Genome Integration of Genetic Code from SARS-CoV-2 Mrna Vaccination","volume":"10","author":"Kyriakopoulos","year":"2022","journal-title":"J. Neurol. Disord."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"109530","DOI":"10.1016\/j.celrep.2021.109530","article-title":"No Evidence of Human Genome Integration of SARS-CoV-2 Found by Long-Read DNA Sequencing","volume":"36","author":"Smits","year":"2021","journal-title":"Cell Rep."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3390\/cimb44040113","article-title":"Comment on Alden et al. Intracellular Reverse Transcription of Pfizer Biontech COVID-19 mRNA Vaccine BNT-162b2 in Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022, 44, 1115\u20131126","volume":"44","author":"Merchant","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e2300048","DOI":"10.1002\/prca.202300048","article-title":"Detection of Recombinant Spike Protein in the Blood of Individuals Vaccinated against SARS-CoV-2: Possible Molecular Mechanisms","volume":"17","author":"Brogna","year":"2023","journal-title":"Proteom. Clin. Appl."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41541-023-00742-7","article-title":"Duration of SARS-CoV-2 mRNA Vaccine Persistence and Factors Associated with Cardiac Involvement in Recently Vaccinated Patients","volume":"8","author":"Krauson","year":"2023","journal-title":"NPJ Vaccines"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"103479","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP Platform\u2019s Lipid Nanoparticle Component Used in Preclinical Vaccine Studies Is Highly Inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e756","DOI":"10.1016\/S2352-3026(20)30186-1","article-title":"Effects of the COVID-19 Pandemic on Supply and Use of Blood for Transfusion","volume":"7","author":"Stanworth","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tmrv.2020.02.003","article-title":"Coronavirus Disease 2019: Coronaviruses and Blood Safety","volume":"34","author":"Chang","year":"2020","journal-title":"Transfus. Med. Rev."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"207","DOI":"10.11604\/pamj.2021.40.207.29119","article-title":"Blood Donor Eligibility after COVID-19 Vaccination: The Current State of Recommendations","volume":"40","author":"Bouhou","year":"2021","journal-title":"Pan Afr. Med. J."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/bjh.17842","article-title":"Refusing Blood Transfusions from COVID-19-Vaccinated Donors: Are We Repeating History?","volume":"196","author":"Jacobs","year":"2022","journal-title":"Br. J. Haematol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"103772","DOI":"10.1016\/j.amsu.2022.103772","article-title":"Effects of SARS-CoV-2 Vaccination on Blood Donation and Blood Banks in India","volume":"78","author":"Hunain","year":"2022","journal-title":"Ann. Med. Surg."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Parry, P.I., Lefringhausen, A., Turni, C., Neil, C.J., Cosford, R., Hudson, N.J., and Gillespie, J. (2023). \u2018Spikeopathy\u2019: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA. Biomedicines, 11.","DOI":"10.3390\/biomedicines11082287"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/apm.13294","article-title":"SARS-CoV-2 Spike mRNA Vaccine Sequences Circulate in Blood up to 28 Days after COVID-19 Vaccination","volume":"131","author":"Castruita","year":"2023","journal-title":"APMIS"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/trf.17616","article-title":"Clinical Outcomes in Hospitalized Plasma and Platelet Transfusion Recipients Prior to and Following Widespread Blood Donor SARS-CoV-2 Infection and Vaccination","volume":"64","author":"Roubinian","year":"2024","journal-title":"Transfusion"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Hanna, N., De Mejia, C.M., Heffes-Doon, A., Lin, X., Botros, B., Gurzenda, E., Clauss-Pascarelli, C., and Nayak, A. (2023). Biodistribution of mRNA COVID-19 Vaccines in Human Breast Milk. EBioMedicine, 96.","DOI":"10.1016\/j.ebiom.2023.104800"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Huynh, T.V., Rethi, L., Lee, T.W., Higa, S., Kao, Y.H., and Chen, Y.J. (2023). Spike Protein Impairs Mitochondrial Function in Human Cardiomyocytes: Mechanisms Underlying Cardiac Injury in COVID-19. Cells, 12.","DOI":"10.3390\/cells12060877"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.freeradbiomed.2023.05.034","article-title":"Toxicity of the Spike Protein of COVID-19 Is a Redox Shift Phenomenon: A Novel Therapeutic Approach","volume":"206","author":"Schwartz","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Forsyth, C.B., Zhang, L., Bhushan, A., Swanson, B., Zhang, L., Mamede, J.I., Voigt, R.M., Shaikh, M., Engen, P.A., and Keshavarzian, A. (2022). The SARS-CoV-2 S1 Spike Protein Promotes Mapk and Nf-Kb Activation in Human Lung Cells and Inflammatory Cytokine Production in Human Lung and Intestinal Epithelial Cells. Microorganisms, 10.","DOI":"10.20944\/preprints202206.0010.v1"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Niu, C., Liang, T., Chen, Y., Zhu, S., Zhou, L., Chen, N., Qian, L., Wang, Y., Li, M., and Zhou, X. (2024). SARS-CoV-2 Spike Protein Induces the Cytokine Release Syndrome by Stimulating T Cells to Produce More Il-2. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1444643"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Robles, J.P., Zamora, M., Adan-Castro, E., Siqueiros-Marquez, L., de la Escalera, G.M., and Clapp, C. (2022). The Spike Protein of SARS-CoV-2 Induces Endothelial Inflammation through Integrin Alpha5beta1 and Nf-Kappab Signaling. J. Biol. Chem., 298.","DOI":"10.1016\/j.jbc.2022.101695"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1042\/CS20210735","article-title":"The SARS-CoV-2 Spike Protein Disrupts Human Cardiac Pericytes Function through Cd147 Receptor-Mediated Signalling: A Potential Non-Infective Mechanism of COVID-19 Microvascular Disease","volume":"135","author":"Avolio","year":"2021","journal-title":"Clin. Sci."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Perico, L., Morigi, M., Galbusera, M., Pezzotta, A., Gastoldi, S., Imberti, B., Perna, A., Ruggenenti, P., Donadelli, R., and Benigni, A. (2022). SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.827146"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Perico, L., Morigi, M., Pezzotta, A., Locatelli, M., Imberti, B., Corna, D., Cerullo, D., Benigni, A., and Remuzzi, G. (2023). SARS-CoV-2 Spike Protein Induces Lung Endothelial Cell Dysfunction and Thrombo-Inflammation Depending on the C3a\/C3a Receptor Signalling. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-38382-5"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Ali, Y.M., Ferrari, M., Lynch, N.J., Yaseen, S., Dudler, T., Gragerov, S., Demopulos, G., Heeney, J.L., and Schwaeble, W.J. (2021). Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.714511"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"101756","DOI":"10.1016\/j.molmet.2023.101756","article-title":"The SARS-CoV-2 Spike Protein Induces Long-Term Transcriptional Perturbations of Mitochondrial Metabolic Genes, Causes Cardiac Fibrosis, and Reduces Myocardial Contractile in Obese Mice","volume":"74","author":"Cao","year":"2023","journal-title":"Mol. Metab."},{"key":"ref_151","first-page":"97","article-title":"Thrombosis after SARS-CoV-2 Infection or COVID-19 Vaccination: Will a Nonpathologic Anti-Pf4 Antibody Be a Solution?-a Narrative Review","volume":"5","author":"Rao","year":"2022","journal-title":"J. BioX Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12185-022-03324-w","article-title":"COVID-19 Microthrombosis: Unusually Large Vwf Multimers Are a Platform for Activation of the Alternative Complement Pathway under Cytokine Storm","volume":"115","author":"Fujimura","year":"2022","journal-title":"Int. J. Hematol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jvs.2020.07.089","article-title":"Early Experience with Arterial Thromboembolic Complications in Patients with COVID-19","volume":"73","author":"Indes","year":"2021","journal-title":"J. Vasc. Surg."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Vettori, M., Dima, F., Henry, B.M., Carpene, G., Gelati, M., Celegon, G., Salvagno, G.L., and Lippi, G. (2023). Effects of Different Types of Recombinant SARS-CoV-2 Spike Protein on Circulating Monocytes\u2019 Structure. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202304.1094.v1"},{"key":"ref_155","first-page":"275","article-title":"Effects of Recombinant SARS-CoV-2 Spike Protein Variants on Platelet Morphology and Activation","volume":"50","author":"Vettori","year":"2023","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/cyto.a.24677","article-title":"Long-Term Effects of Pfizer-Biontech COVID-19 Vaccinations on Platelets","volume":"103","author":"Zhou","year":"2023","journal-title":"Cytometry A"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1055\/s-0042-1748193","article-title":"D-Dimers-Normal Levels Versus Elevated Levels Due to a Range of Conditions, Including D-Dimeritis, Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19","volume":"48","author":"Thachil","year":"2022","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Grobbelaar, L.M., Venter, C., Vlok, M., Ngoepe, M., Laubscher, G.J., Lourens, P.J., Steenkamp, J., Kell, D.B., and Pretorius, E. (2021). SARS-CoV-2 Spike Protein S1 Induces Fibrin(Ogen) Resistant to Fibrinolysis: Implications for Microclot Formation in COVID-19. Biosci. Rep., 41.","DOI":"10.1042\/BSR20210611"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s11481-021-10029-0","article-title":"SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity Via Rhoa Activation","volume":"16","author":"DeOre","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Montezano, A.C., Camargo, L.L., Mary, S., Neves, K.B., Rios, F.J., Stein, R., Lopes, R.A., Beattie, W., Thomson, J., and Herder, V. (2023). SARS-CoV-2 Spike Protein Induces Endothelial Inflammation Via Ace2 Independently of Viral Replication. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-41115-3"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Szebeni, J., and Koller, A. (2025). Systemic Endothelial Inflammation: A Key Driver of Adverse Reactions to mRNA-Containing COVID-19 Vaccines. Vaccines, 13.","DOI":"10.20944\/preprints202505.2293.v1"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"D\u00e9zsi, L., K\u00f6k\u00e9ny, G., Sz\u00e9n\u00e1si, G., R\u00e9v\u00e9sz, C., M\u00e9sz\u00e1ros, T., Barta, B.A., Facsko, R., Szilasi, A., Bakos, T., and Kozma, G.T. (2025). Acute Anaphylactic and Multiorgan Inflammatory Effects of Comirnaty in Pigs: Evidence of Spike Protein mRNA Transfection and Paralleling Inflammatory Cytokine Upregulation. bioRxiv, 1\u201328.","DOI":"10.1101\/2025.06.07.658379"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1093\/infdis\/jiu184","article-title":"Vaccine-Associated Paralytic Poliomyelitis: A Review of the Epidemiology and Estimation of the Global Burden","volume":"210","author":"Platt","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/00006454-198908000-00006","article-title":"Analyses of Adverse Reactions to Diphtheria and Tetanus Toxoids and Pertussis Vaccine by Vaccine Lot, Endotoxin Content, Pertussis Vaccine Potency and Percentage of Mouse Weight Gain","volume":"8","author":"Baraff","year":"1989","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00006454-199004000-00014","article-title":"Effect of Needle Change and Air Bubble in Syringe on Minor Adverse Reactions Associated with Diphtheria-Tetanus Toxoids-Pertussis-Polio Vaccination in Infants","volume":"9","author":"Ipp","year":"1990","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1086\/315558","article-title":"Evaluation of a Single Dose of Diphtheria-Tetanus Toxoids among Adults in Odessa, Ukraine, 1995: Immunogenicity and Adverse Reactions","volume":"181","author":"Golaz","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0264-410X(97)00288-0","article-title":"Rational Approaches to Reduce Adverse Reactions in Man to Vaccines Containing Tetanus and Diphtheria Toxoids","volume":"16","author":"Relyveld","year":"1998","journal-title":"Vaccine"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.anai.2019.06.006","article-title":"Successful Vaccination with Tetanus and Diphtheria and Acelluar Pertussis Vaccine after Adverse Reaction to Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine or Diphtheria and Tetanus Vaccine in Pediatric Patients","volume":"123","author":"Campbell","year":"2019","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_169","unstructured":"Dall, C. (2025, September 22). Pediatric RSV Vaccine Trials on Hold, Fda Says. CIDRAP. Available online: https:\/\/www.cidrap.umn.edu\/respiratory-syncytial-virus-rsv\/pediatric-rsv-vaccine-trials-hold-fda-says?utm_source=chatgpt.com."},{"key":"ref_170","unstructured":"FDA (2025, September 22). Vaccines and Related Biological Products Advisory Committee Meeting: Considerations for Respiratory Syncytial Virus (RSV) Vaccine Safetyin Pediatric Populations, FDA Briefing Document December 12, 2024, Available online: https:\/\/www.fda.gov\/media\/184301\/download?utm_source=chatgpt.com."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2015.08.051","article-title":"N(1)-Methylpseudouridine-Incorporated mRNA Outperforms Pseudouridine-Incorporated mRNA by Providing Enhanced Protein Expression and Reduced Immunogenicity in Mammalian Cell Lines and Mice","volume":"217","author":"Andries","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"e29183","DOI":"10.1002\/jmv.29183","article-title":"Viral Codon Optimization on SARS-CoV-2 Spike Boosts Immunity in the Development of COVID-19 mRNA Vaccines","volume":"95","author":"Lai","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Kachaev, Z.M., Lebedeva, L.A., Kozlov, E.N., and Shidlovskii, Y.V. (2020). Interplay of mRNA Capping and Transcription Machineries. Biosci. Rep., 40.","DOI":"10.1042\/BSR20192825"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"10788","DOI":"10.1093\/nar\/gkae763","article-title":"Trinucleotide Cap Analogs with Triphosphate Chain Modifications: Synthesis, Properties, and Evaluation as mRNA Capping Reagents","volume":"52","author":"Warminski","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.3762\/bjoc.13.274","article-title":"Synthetic mRNA Capping","volume":"13","author":"Muttach","year":"2017","journal-title":"Beilstein J. Org. Chem."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/nar\/gkac1207","article-title":"Crystal Structures and Fragment Screening of SARS-CoV-2 Nsp14 Reveal Details of Exoribonuclease Activation and mRNA Capping and Provide Starting Points for Antiviral Drug Development","volume":"51","author":"Imprachim","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Jin, L., Zhou, Y., Zhang, S., and Chen, S.J. (2024). mRNA Vaccine Sequence and Structure Design and Optimization: Advances and Challenges. J. Biol. Chem., 301.","DOI":"10.1016\/j.jbc.2024.108015"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Wang, Y.S., Kumari, M., Chen, G.H., Hong, M.H., Yuan, J.P., Tsai, J.L., and Wu, H.C. (2023). mRNA-Based Vaccines and Therapeutics: An in-Depth Survey of Current and Upcoming Clinical Applications. J. Biomed. Sci., 30.","DOI":"10.1186\/s12929-023-00977-5"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.cels.2024.05.004","article-title":"Decoupled Degradation and Translation Enables Noise Modulation by Poly(a) Tails","volume":"15","author":"Grandi","year":"2024","journal-title":"Cell Syst."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-4939-6481-9_5","article-title":"Rnactive(R) Technology: Generation and Testing of Stable and Immunogenic mRNA Vaccines","volume":"1499","author":"Rauch","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-0716-3770-8_8","article-title":"Sequence-Optimized mRNA Vaccines against Infectious Disease","volume":"2786","author":"Rauch","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-3770-8_1","article-title":"Introduction to RNA Vaccines Post COVID-19","volume":"2786","author":"Kramps","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12967-024-06033-6","article-title":"mRNA Vaccines in the Context of Cancer Treatment: From Concept to Application","volume":"23","author":"Fu","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1261\/rna.1007408","article-title":"Nucleoside Modifications Modulate Activation of the Protein Kinase Pkr in an RNA Structure-Specific Manner","volume":"14","author":"Nallagatla","year":"2008","journal-title":"RNA"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"9687","DOI":"10.1128\/JVI.00738-06","article-title":"Reduction of the Rate of Poliovirus Protein Synthesis through Large-Scale Codon Deoptimization Causes Attenuation of Viral Virulence by Lowering Specific Infectivity","volume":"80","author":"Mueller","year":"2006","journal-title":"J. Virol."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Bentele, K., Saffert, P., Rauscher, R., Ignatova, Z., and Bluthgen, N. (2013). Efficient Translation Initiation Dictates Codon Usage at Gene Start. Mol. Syst. Biol., 9.","DOI":"10.1038\/msb.2013.32"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Scharff, L.B., Childs, L., Walther, D., and Bock, R. (2011). Local Absence of Secondary Structure Permits Translation of mRNAs That Lack Ribosome-Binding Sites. PLoS Genet., 7.","DOI":"10.1371\/journal.pgen.1002155"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1016\/j.csbj.2022.05.041","article-title":"Secondary Structures in Rna Synthesis, Splicing and Translation","volume":"20","author":"Parada","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(02)01056-9","article-title":"Pushing the Limits of the Scanning Mechanism for Initiation of Translation","volume":"299","author":"Kozak","year":"2002","journal-title":"Gene"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"111223","DOI":"10.1016\/j.jocn.2025.111223","article-title":"Expression of SARS-CoV-2 Spike Protein in Cerebral Arteries: Implications for Hemorrhagic Stroke Post-mRNA Vaccination","volume":"136","author":"Ota","year":"2025","journal-title":"J. Clin. Neurosci."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-Based Design of Prefusion-Stabilized SARS-CoV-2 Spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41467-023-37786-1","article-title":"High-Throughput Identification of Prefusion-Stabilizing Mutations in SARS-CoV-2 Spike","volume":"14","author":"Tan","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature17200","article-title":"Pre-Fusion Structure of a Human Coronavirus Spike Protein","volume":"531","author":"Kirchdoerfer","year":"2016","journal-title":"Nature"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and Structures of a Rationally Designed Prefusion Mers-Cov Spike Antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41467-020-20321-x","article-title":"Stabilizing the Closed SARS-CoV-2 Spike Trimer","volume":"12","author":"Juraszek","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11306-024-02173-4","article-title":"Nutritional Deuterium Depletion and Health: A Scoping Review","volume":"20","author":"Korchinsky","year":"2024","journal-title":"Metabolomics"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2021.12.027","article-title":"Added to Pre-Existing Inflammation, mRNA-Lipid Nanoparticles Induce Inflammation Exacerbation (Ie)","volume":"344","author":"Parhiz","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1038\/s41467-021-23546-6","article-title":"Nucleoside-Modified VEGF mRNA Induces Organ-Specific Lymphatic Growth and Reverses Experimental Lymphedema","volume":"12","author":"Szoke","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41565-022-01071-x","article-title":"Applying Lessons Learned from Nanomedicines to Understand Rare Hypersensitivity Reactions to mRNA-Based SARS-CoV-2 Vaccines","volume":"17","author":"Szebeni","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"ref_200","unstructured":"Pfizer Australia Pty Ltd. (2025, September 22). Nonclinical Evaluation Report: BNT162b2 [mRNA] COVID-19 Vaccine (Comirnaty), Available online: https:\/\/www.tga.gov.au\/sites\/default\/files\/foi-2389-06.pdf."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"13983","DOI":"10.1021\/acsnano.4c00182","article-title":"Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions","volume":"18","author":"Anchordoquy","year":"2024","journal-title":"ACS Nano"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"115175","DOI":"10.1016\/j.addr.2023.115175","article-title":"The Immunostimulatory Nature of mRNA Lipid Nanoparticles","volume":"205","author":"Sharma","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000467894","article-title":"Anaphylatoxins: Possible Roles in Disease","volume":"3","author":"Vogt","year":"1986","journal-title":"Complement"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Schanzenbacher, J., Kohl, J., and Karsten, C.M. (2022). Anaphylatoxins Spark the Flame in Early Autoimmunity. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.958392"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/bi00832a038","article-title":"Antibody Binding and Complement Fixation by a Liposomal Model Membrane","volume":"8","author":"Alving","year":"1969","journal-title":"Biochemistry"},{"key":"ref_206","first-page":"567","article-title":"Complement Activation-Related Pseudoallergy Caused by Liposomes, Micellar Carriers of Intravenous Drugs, and Radiocontrast Agents","volume":"18","author":"Szebeni","year":"2001","journal-title":"Crit. Rev.\u2122 Ther. Drug Carr. Syst."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tox.2005.07.023","article-title":"Complement Activation-Related Pseudoallergy: A New Class of Drug-Induced Acute Immune Toxicity","volume":"216","author":"Szebeni","year":"2005","journal-title":"Toxicology"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.molimm.2014.06.038","article-title":"Complement Activation-Related Pseudoallergy: A Stress Reaction in Blood Triggered by Nanomedicines and Biologicals","volume":"61","author":"Szebeni","year":"2014","journal-title":"Mol. Immunol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11357-021-00495-y","article-title":"A Naturally Hypersensitive Porcine Model May Help Understand the Mechanism of COVID-19 mRNA Vaccine-Induced Rare (Pseudo) Allergic Reactions: Complement Activation as a Possible Contributing Factor","volume":"44","author":"Dezsi","year":"2022","journal-title":"Geroscience"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"de Vrieze, J. (2025, September 30). Suspicions Grow That Nanoparticles in Pfizer\u2019s COVID-19 Vaccine Trigger Rare Allergic Reactions. ScienceInsider\/News Piece, Published Online December 21, 2020. Available online: https:\/\/doi.org\/10.1126\/science.abg2359.","DOI":"10.1126\/science.abg2359"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.CIR.99.17.2302","article-title":"Hemodynamic Changes Induced by Liposomes and Liposome-Encapsulated Hemoglobin in Pigs: A Model for Pseudoallergic Cardiopulmonary Reactions to Liposomes: Role of Complement and Inhibition by Soluble Cr1 and Anti-C5a Antibody","volume":"99","author":"Szebeni","year":"1999","journal-title":"Circulation"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5414\/ALX02374E","article-title":"Anaphylactic Reactions after COVID-19 Vaccination in Germany","volume":"7","author":"Barth","year":"2023","journal-title":"Allergol. Sel."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"100497","DOI":"10.1016\/j.jvacx.2024.100497","article-title":"Comirnaty-Induced Cardiopulmonary Distress and Other Symptoms of Complement-Mediated Pseudo-Anaphylaxis in a Hyperimmune Pig Model: Causal Role of Anti-Peg Antibodies","volume":"19","author":"Barta","year":"2024","journal-title":"Vaccine X"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/wnan.1339","article-title":"Anti-Peg Immunity: Emergence, Characteristics, and Unaddressed Questions","volume":"7","author":"Yang","year":"2015","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1021\/acsnano.9b07218","article-title":"Premature Drug Release from Polyethylene Glycol (PEG)-Coated Liposomal Doxorubicin Via Formation of the Membrane Attack Complex","volume":"14","author":"Chen","year":"2020","journal-title":"ACS Nano"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-Peg Antibodies: Properties, Formation, Testing and Role in Adverse Immune Reactions to Pegylated Nano-Biopharmaceuticals","volume":"154\u2013155","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1021\/acsnano.0c03648","article-title":"Complement Activation: A Potential Threat on the Safety of Poly(Ethylene Glycol)-Coated Nanomedicines","volume":"14","author":"Gabizon","year":"2020","journal-title":"ACS Nano"},{"key":"ref_218","unstructured":"USFDA (2025, September 22). Guidance for Industry: Immunogenicity Assessment for Therapeutic Protein Products, Available online: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/immunogenicity-assessment-therapeutic-protein-products."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.immuni.2020.11.009","article-title":"SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation","volume":"53","author":"Lederer","year":"2020","journal-title":"Immunity"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid Nanoparticles Enhance the Efficacy of mRNA and Protein Subunit Vaccines by Inducing Robust T Follicular Helper Cell and Humoral Responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.immuni.2022.05.007","article-title":"Lipid Nanoparticles Enhance the Efficacy of mRNA and Protein Subunit Vaccines by Inducing Robust T Follicular Helper Cell and Humoral Responses","volume":"55","author":"Alameh","year":"2022","journal-title":"Immunity"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41565-023-01371-w","article-title":"Active Ingredient Vs Excipient Debate for Nanomedicines","volume":"18","author":"Hemmrich","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression Kinetics of Nucleoside-Modified mRNA Delivered in Lipid Nanoparticles to Mice by Various Routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"101314","DOI":"10.1016\/j.omtm.2024.101314","article-title":"Protein Is Expressed in All Major Organs after Intravenous Infusion of mRNA -Lipid Nanoparticles in Swine","volume":"32","author":"Ferraresso","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0065-2776(08)04004-2","article-title":"The Amplification Loop of the Complement Pathways","volume":"104","author":"Lachmann","year":"2009","journal-title":"Adv. Immunol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacig.2022.10.003","article-title":"The Conundrum of COVID-19 mRNA Vaccine-Induced Anaphylaxis","volume":"2","author":"Khalid","year":"2023","journal-title":"J. Allergy Clin. Immunol. Glob."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity","volume":"271","author":"Dempsey","year":"1996","journal-title":"Science"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1513\/pats.200704-046AW","article-title":"Complement Activation Pathways: A Bridge between Innate and Adaptive Immune Responses in Asthma","volume":"4","year":"2007","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1016\/j.vaccine.2023.06.009","article-title":"Role of Anti-Polyethylene Glycol (Peg) Antibodies in the Allergic Reactions to PEG-Containing COVID-19 Vaccines: Evidence for Immunogenicity of Peg","volume":"41","author":"Kozma","year":"2023","journal-title":"Vaccine"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1016\/j.vaccine.2022.08.024","article-title":"mRNA-1273 but Not Bnt162b2 Induces Antibodies against Polyethylene Glycol (Peg) Contained in mRNA-Based Vaccine Formulations","volume":"40","author":"Carreno","year":"2022","journal-title":"Vaccine"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-Peg Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jconrel.2022.12.039","article-title":"Anti-PEG Antibodies before and after a First Dose of ComirnatyR (mRNA-LNP-Based SARS-CoV-2 Vaccine)","volume":"354","author":"Bavli","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"e2303370","DOI":"10.1002\/adma.202303370","article-title":"Induction of Bleb Structures in Lipid Nanoparticle Formulations of mRNA Leads to Improved Transfection Potency","volume":"35","author":"Cheng","year":"2023","journal-title":"Adv. Mater."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"9746","DOI":"10.1021\/acsnano.4c02610","article-title":"Mesoscopic Structure of Lipid Nanoparticle Formulations for mRNA Drug Delivery: Comirnaty and Drug-Free Dispersions","volume":"18","author":"Unruh","year":"2024","journal-title":"ACS Nano"},{"key":"ref_235","unstructured":"Pfizer, and BioNtech (2025, September 22). Comirnaty Original\/Omicron Ba.4-5 Dispersion for Injection. Available online: https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=19823."},{"key":"ref_236","unstructured":"Raoult, D. (2024). Confirmation of the Presence of Vaccine DNA in the Pfizer Anti-COVID-19 Vaccine. Hal Open Sci., 04778576."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"249","DOI":"10.56098\/ijvtpr.v2i1.37","article-title":"Foreign Materials in Blood Samples of Recipients of COVID19 Vaccines","volume":"2","author":"Lee","year":"2022","journal-title":"Int. J. Vaccine Theory Pract. Res."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.56098\/mt1njj52","article-title":"At Least 55 Undeclared Chemical Elements Found in COVID-19 Vaccines from Astrazeneca, Cansino, Moderna, Pfizer, Sinopharm and Sputnik V, with Precise Icp-Ms","volume":"3","author":"Diblasi","year":"2024","journal-title":"Int. J. Vaccine Theory Pract. Res."},{"key":"ref_239","first-page":"2019","article-title":"Biontech Rna-Based COVID-19 Injections Contain Large Amounts of Residual DNA Including an Sv40 Promoter\/Enhancer Sequence","volume":"5","author":"Schulz","year":"2024","journal-title":"Sci. Public. Health Policy Law"},{"key":"ref_240","unstructured":"CGC (2025, September 22). Case Briefing Document. Available online: http:\/\/ukcitizen2021.org\/Case_Briefing_Document_and_lab_report_Ref_AUC_101_Report%20.pdf."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/ard.42.3.285","article-title":"Activation of the Alternative Pathway of Complement by Monosodium Urate Monohydrate Crystals and Other Inflammatory Particles","volume":"42","author":"Doherty","year":"1983","journal-title":"Ann. Rheum. Dis."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0090-1229(82)90235-5","article-title":"Activation of the Fifth Component of Human Complement (C5) Induced by Monosodium Urate Crystals: C5 Convertase Assembly on the Crystal Surface","volume":"24","author":"Russell","year":"1982","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0090-1229(83)90143-5","article-title":"Activation of the Alternative Pathway of Complement by Monosodium Urate Crystals","volume":"26","author":"Fields","year":"1983","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1567-5769(01)00006-6","article-title":"Formation of Complement-Activating Particles in Aqueous Solutions of Taxol: Possible Role in Hypersensitivity Reactions","volume":"1","author":"Szebeni","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"ref_245","first-page":"221","article-title":"Complement-Dependent Shock and Tissue Damage Induced by Intravenous Injection of Cholesterol-Enriched Liposomes in Rats","volume":"3","author":"Baranyi","year":"2003","journal-title":"J. Appl. Res."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/leu.2010.53","article-title":"Novel Insight into Stem Cell Mobilization-Plasma Sphingosine-1-Phosphate Is a Major Chemoattractant That Directs the Egress of Hematopoietic Stem Progenitor Cells from the Bone Marrow and Its Level in Peripheral Blood Increases During Mobilization Due to Activation of Complement Cascade\/Membrane Attack Complex","volume":"24","author":"Ratajczak","year":"2010","journal-title":"Leukemia"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0142-9612(83)90007-8","article-title":"Activation of Complement C3 by Different Calcium Phosphate Powders","volume":"4","author":"Klein","year":"1983","journal-title":"Biomaterials"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0091-6749(79)90147-7","article-title":"Binding of Immunoglobulin and Activation of Complement by Asbestos Fibers","volume":"64","author":"Hasselbacher","year":"1979","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"eabn3464","DOI":"10.1126\/scitranslmed.abn3464","article-title":"Single Immunizations of Self-Amplifying or Non-Replicating mRNA-LNP Vaccines Control HPV-Associated Tumors in Mice","volume":"15","author":"Rodrigues","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_250","first-page":"e50703","article-title":"SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of Oncogenesis","volume":"15","year":"2023","journal-title":"Cureus"},{"key":"ref_251","unstructured":"Kruger, U. (2025, September 22). COVID Vaccination and Turbo-Cancer. Multiple Tumors in Multiple Organs. Available online: https:\/\/www.globalresearch.ca\/turbo-cancer-we-have-problem\/5789172."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.clml.2023.03.002","article-title":"Response to COVID-19 Vaccination Post-Car T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma","volume":"23","author":"Iqbal","year":"2023","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_253","doi-asserted-by":"crossref","unstructured":"Sekizawa, A., Hashimoto, K., Kobayashi, S., Kozono, S., Kobayashi, T., Kawamura, Y., Kimata, M., Fujita, N., Ono, Y., and Obuchi, Y. (2022). Rapid Progression of Marginal Zone B-Cell Lymphoma after COVID-19 Vaccination (BNT-162b2): A Case Report. Front. Med., 9.","DOI":"10.3389\/fmed.2022.963393"},{"key":"ref_254","first-page":"e57860","article-title":"Increased Age-Adjusted Cancer Mortality after the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan","volume":"16","author":"Gibo","year":"2024","journal-title":"Cureus"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.4049\/jimmunol.0800771","article-title":"B Cell Proliferation, Somatic Hypermutation, Class Switch Recombination, and Autoantibody Production in Ectopic Lymphoid Tissue in Murine Lupus","volume":"182","author":"Nacionales","year":"2009","journal-title":"J. Immunol."},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Gentilini, P., Lindsay, J.C., Konishi, N., Fukushima, M., and Polykretis, P. (2024). A Case Report of Acute Lymphoblastic Leukaemia (ALL)\/Lymphoblastic Lymphoma (LBL) Following the Second Dose of Comirnaty\u00ae: An Analysis of the Potential Pathogenic Mechanism Based on of the Existing Literature. Preprints, 2024031661.","DOI":"10.20944\/preprints202403.1661.v1"},{"key":"ref_257","first-page":"295","article-title":"The Environment and Disease: Association or Causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc. R. Soc. Med."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40425-019-0549-5","article-title":"Lymphopenia in Cancer Patients and Its Effects on Response to Immunotherapy: An Opportunity for Combination with Cytokines?","volume":"7","author":"Blay","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"275","DOI":"10.18632\/oncotarget.28582","article-title":"Transfected SARS-CoV-2 Spike DNA for Mammalian Cell Expression Inhibits P53 Activation of P21(Waf1), Trail Death Receptor Dr5 and Mdm2 Proteins in Cancer Cells and Increases Cancer Cell Viability after Chemotherapy Exposure","volume":"15","author":"Zhang","year":"2024","journal-title":"Oncotarget"},{"key":"ref_260","first-page":"262","article-title":"Predictive Value of Pseudouridine in Prostate Cancer","volume":"7","author":"Stockert","year":"2019","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.urolonc.2020.06.026","article-title":"Pseudouridine as a Novel Biomarker in Prostate Cancer","volume":"39","author":"Stockert","year":"2021","journal-title":"Urol. Oncol."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.semcancer.2020.11.007","article-title":"RNA Methylations in Human Cancers","volume":"75","author":"Han","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"267","DOI":"10.37349\/ei.2024.00140","article-title":"Exploring the Possible Link between the Spike Protein Immunoglobulin G4 Antibodies and Cancer Progression","volume":"4","author":"Raszek","year":"2024","journal-title":"Explor. Immunol."},{"key":"ref_264","first-page":"1","article-title":"Micro-Rnas: The New Potential Biomarkers in Cancer Diagnosis, Prognosis and Cancer Therapy","volume":"61","author":"Mansoori","year":"2015","journal-title":"Cell. Mol. Biol."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"2065837","DOI":"10.1080\/21645515.2022.2065837","article-title":"Microrna-873-5p Suppresses Cell Malignant Behaviors of Thyroid Cancer Via Targeting Cxcl5 and Regulating P53 Pathway","volume":"18","author":"Chang","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_266","doi-asserted-by":"crossref","unstructured":"Trifylli, E.M., Kriebardis, A.G., Koustas, E., Papadopoulos, N., Fortis, S.P., Tzounakas, V.L., Anastasiadi, A.T., Sarantis, P., Vasileiadi, S., and Tsagarakis, A. (2024). A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-mRNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063406"},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Maiese, A., Baronti, A., Manetti, A.C., Di Paolo, M., Turillazzi, E., Frati, P., and Fineschi, V. (2022). Death after the Administration of COVID-19 Vaccines Approved by Ema: Has a Causal Relationship Been Demonstrated?. Vaccines, 10.","DOI":"10.3390\/vaccines10020308"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global Impact of the First Year of COVID-19 Vaccination: A Mathematical Modelling Study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"2101021","DOI":"10.2807\/1560-7917.ES.2021.26.47.2101021","article-title":"Estimated Number of Deaths Directly Averted in People 60 Years and Older as a Result of COVID-19 Vaccination in the Who European Region, December 2020 to November 2021","volume":"26","author":"Mesle","year":"2021","journal-title":"Eurosurveillance"},{"key":"ref_270","first-page":"001","article-title":"The Discrepancy Between the Number of Saved Lives with COVID-19 Vaccination and Statistics of Our World Data","volume":"S32","author":"Sorli","year":"2025","journal-title":"J. Clin. Trials"},{"key":"ref_271","unstructured":"Beattie, K.A. (2021). Worldwide Bayesian Causal Impact Analysis of Vaccine Administration on Deaths and Cases Associated with COVID-19: A Bigdata Analysis of 145 Countries. Preprint."},{"key":"ref_272","first-page":"584","article-title":"Significant Increase in Excess Deaths after Repeated COVID-19 Vaccination in Japan","volume":"8","author":"Kakeya","year":"2025","journal-title":"JMA J."},{"key":"ref_273","doi-asserted-by":"crossref","unstructured":"Yaraghi, P., Kheyri, A., Mikaeili, N., Boroumand, A., Abbasifard, M., Farhangnia, P., Rezagholizadeh, F., and Khorramdelazad, H. (2025). Nanoparticle-Mediated Enhancement of DNA Vaccines: Revolutionizing Immunization Strategies. Int. J. Biol. Macromol., 302.","DOI":"10.1016\/j.ijbiomac.2025.140558"},{"key":"ref_274","doi-asserted-by":"crossref","unstructured":"Saleh, M., El-Moghazy, A., Elgohary, A.H., Saber, W.I.A., and Helmy, Y.A. (2025). Revolutionizing Nanovaccines: A New Era of Immunization. Vaccines, 13.","DOI":"10.3390\/vaccines13020126"},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12985-025-02645-6","article-title":"Revolutionizing Immunization: A Comprehensive Review of mRNA Vaccine Technology and Applications","volume":"22","author":"Leong","year":"2025","journal-title":"Virol. J."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and Safety of an mRNA-Based Rsv Pref Vaccine in Older Adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_277","unstructured":"ModernaTX, Inc. (2025, September 30). Prescribing Information: (Respiratory Syncytial Virus Vaccine) Injectable Suspension, for Intramuscular Use, Available online: https:\/\/www.fda.gov\/media\/179005\/download?attachment=&utm_source=chatgpt.com."},{"key":"ref_278","unstructured":"FDA (2025, September 22). FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines to Better Protect against Currently Circulating Variants, FDA New Release, Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-and-authorizes-updated-mrna-covid-19-vaccines-better-protect-against-currently."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41392-023-01579-1","article-title":"mRNA Vaccines in Disease Prevention and Treatment","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_280","doi-asserted-by":"crossref","unstructured":"Ladak, R.J., He, A.J., Huang, Y.H., and Ding, Y. (2022). The Current Landscape of mRNA Vaccines against Viruses and Cancer-a Mini Review. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.885371"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41571-024-00902-1","article-title":"Cancer mRNA Vaccines: Clinical Advances and Future Opportunities","volume":"21","author":"Sayour","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/d41573-021-00147-y","article-title":"Evolution of the Market for mRNA Technology","volume":"20","author":"Xie","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_283","unstructured":"Insights, Fortune Business (2025, September 30). Lipid Nanoparticles Market Size, Share & Industry Analysis, by Type (Solid Lipid Nanoparticles (SLNP), Nanostructured Lipid Carriers (NSLC), and Others), by Application (Therapeutics, Research), by End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others), and Regional Forecast, 2024\u20132032. Available online: https:\/\/www.fortunebusinessinsights.com\/lipid-nanoparticles-market-106960."},{"key":"ref_284","unstructured":"Intelligence, Mordor (2025, September 22). mRNA Vaccine and Therapeutics Market Size & Share Analysis\u2014Growth Trends & Forecasts (2024\u20132029). Available online: https:\/\/www.mordorintelligence.com\/industry-reports\/mrna-vaccines-and-therapeutics-market."},{"key":"ref_285","unstructured":"Nathan-Kazis, J., and Kennedy\u2019s Edict Results in New, Narrowed Vaccine Guidance from CDC (2025, September 30). Barron\u2019s Online 30 May 2025. Available online: https:\/\/www.barrons.com\/articles\/vaccines-cdc-covid-19-pregnant-women-children-kennedy-6f19ab5f."},{"key":"ref_286","unstructured":"(2025, September 22). Food and Drug Administration: FDA Approves Required Updated Warning in Labeling of mRNA COVID-19 Vaccines Regarding Myocarditis and Pericarditis Following Vaccination 25 June 2025, Available online: https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/fda-approves-required-updated-warning-labeling-mrna-covid-19-vaccines-regarding-myocarditis-and."},{"key":"ref_287","unstructured":"Scribner, H., and Rubin, A. (2025, September 22). A Guide to the New COVID Vaccine Recommendations. AXIOS, Available online: https:\/\/www.axios.com\/2025\/08\/28\/cdc-covid-vaccine-rules-recommendations-high-risk-fda."},{"key":"ref_288","unstructured":"Lim, D. (2025, September 22). 2025. FDA Revokes Emergency Use of COVID-19 Vaccines. Politico, 27 August. Available online: https:\/\/www.politico.com\/news\/2025\/08\/27\/fda-revokes-emergency-use-of-covid-19-vaccines-00530626."},{"key":"ref_289","unstructured":"Daily Beast (2025, September 22). 2025 RFK Jr. Celebrates as FDA Ends COVID Vaccine Mandate 27 August 2025. Available online: https:\/\/www.thedailybeast.com\/rfk-jr-celebrates-as-fda-ends-covid-vaccine-mandate."},{"key":"ref_290","unstructured":"El-Deiry, W., and Kupperwasser, C. (2025, September 22). Workup Safety Uncertainties of mRNA COVID Vaccines. Meeting of the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, Atlanta, GA, 18\u201319 September 2025, Available online: https:\/\/www.cdc.gov\/acip\/downloads\/agendas\/final-posted-2025-09-19-508.pdf."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"977","DOI":"10.15585\/mmwr.mm7027e2","article-title":"Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices\u2014United States, June 2021","volume":"70","author":"Gargano","year":"2021","journal-title":"MMWR-Morb. Mortal. Wkly. Rep."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"e248192","DOI":"10.1001\/jamanetworkopen.2024.8192","article-title":"Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 Years","volume":"7","author":"Hu","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jacbts.2024.05.005","article-title":"A Murine Model of mRNA COVID-19 Vaccine-Induced Myocarditis: A Shot in the Dark?","volume":"9","author":"Eens","year":"2024","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_294","doi-asserted-by":"crossref","unstructured":"Zuin, M., Zimelli, E., Valle, C.D., Cavedon, S., Rigatelli, G., and Bilato, C. (2023). Diagnosis of Acute Myocarditis Following mRNA Vaccines against SARS-CoV-2: A Methodological Review. Viruses, 15.","DOI":"10.3390\/v15040929"},{"key":"ref_295","doi-asserted-by":"crossref","unstructured":"Zirkenbach, V.A., Ignatz, R.M., \u00d6ttl, R., Cehreli, Z., Stroikova, V., Kaya, M., Lehmann, L.H., Preusch, M.R., Frey, N., and Kaya, Z. (2023). Effect of SARS-CoV-2 mRNA-Vaccine on the Induction of Myocarditis in Different Murine Animal Models. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24055011"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/00015385.2023.2165271","article-title":"COVID-19 BNT162b2 mRNA vaccine induced myocarditis with left ventricular thrombus in a young male","volume":"78","author":"Yeni","year":"2023","journal-title":"Acta Cardiol."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jgf2.604","article-title":"Acute Myocarditis after the Third Dose of COVID-19 mRNA-1273 Vaccine","volume":"24","author":"Yamada","year":"2023","journal-title":"J. Gen. Fam. Med."},{"key":"ref_298","first-page":"141","article-title":"Facing COVID-19: Myocarditis following vaccination with mRNA SARS-CoV-2","volume":"78","author":"Weerts","year":"2023","journal-title":"Rev. Medicale Liege"},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.hlc.2023.01.002","article-title":"Acute Myocarditis and Pericarditis after mRNA COVID-19 Vaccinations-a Single-Centre Retrospective Analysis","volume":"32","author":"Wassif","year":"2023","journal-title":"Heart Lung Circ."},{"key":"ref_300","first-page":"655","article-title":"Fulminant myocarditis following SARS-CoV-2 mRNA vaccination rescued with venoarterial ECMO: A report of two cases","volume":"39","author":"Uribarri","year":"2023","journal-title":"Perfusion"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ihj.2023.06.009","article-title":"Do COVID-19 viral infection and its mRNA vaccine carry an equivalent risk of myocarditis? Review of the current evidence, insights, and future directions","volume":"75","author":"Ulucay","year":"2023","journal-title":"Indian Heart J."},{"key":"ref_302","doi-asserted-by":"crossref","unstructured":"Tome, J., Cowan, L.T., and Fung, I.C.-H. (2023). A Pharmacoepidemiological Study of Myocarditis and Pericarditis Following the First Dose of mRNA COVID-19 Vaccine in Europe. Microorganisms, 11.","DOI":"10.3390\/microorganisms11051099"},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"e544","DOI":"10.1093\/cid\/ciac446","article-title":"Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide","volume":"76","author":"Straus","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_304","doi-asserted-by":"crossref","unstructured":"Stowe, J., Miller, E., Andrews, N., and Whitaker, H.J. (2023). Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England. PLoS Med., 20.","DOI":"10.1371\/journal.pmed.1004245"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"76","DOI":"10.24171\/j.phrp.2023.0032","article-title":"The incidence and clinical characteristics of myocarditis and pericarditis following mRNA-based COVID-19 vaccination in Republic of Korea adolescents from July 2021 to September 2022","volume":"14","author":"Sim","year":"2023","journal-title":"Osong Public Health Res. Perspect."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/jpc.16498","article-title":"Life-Threatening Severe Acute Respiratory Syndrome Coronavirus-2 mRNA Vaccine-Associated Myocarditis after COVID-19 Myocarditis","volume":"59","author":"Shime","year":"2023","journal-title":"J. Paediatr. Child Health"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"100350","DOI":"10.1016\/j.jvacx.2023.100350","article-title":"Myocarditis following COVID-19 mRNA vaccinations: Twin and sibling case series","volume":"14","author":"Shenton","year":"2023","journal-title":"Vaccine X"},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/CIRCRESAHA.122.321881","article-title":"Vaccination-Associated Myocarditis and Myocardial Injury","volume":"132","author":"Altman","year":"2023","journal-title":"Circ. Res."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/jama.2021.21699","article-title":"Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older","volume":"327","author":"Jabagi","year":"2022","journal-title":"JAMA"},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.7326\/M22-0988","article-title":"Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France","volume":"175","author":"Botton","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"317","DOI":"10.15585\/mmwr.mm7314a5","article-title":"Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine\u2014Oregon, June 2021\u2013December 2022","volume":"73","author":"Liko","year":"2024","journal-title":"MMWR-Morb. Mortal. Wkly. Rep."},{"key":"ref_312","first-page":"e932899-e2","article-title":"Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)","volume":"27","author":"Parums","year":"2021","journal-title":"Med. Sci. Monit."},{"key":"ref_313","doi-asserted-by":"crossref","unstructured":"Rzymski, P., Perek, B., and Flisiak, R. (2021). Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism. Vaccines, 9.","DOI":"10.3390\/vaccines9060559"},{"key":"ref_314","doi-asserted-by":"crossref","unstructured":"Ostrowski, S.R., S\u00f8gaard, O.S., Tolstrup, M., St\u00e6rke, N.B., Lundgren, J., \u00d8stergaard, L., and Hvas, A.-M. (2021). Inflammation and Platelet Activation After COVID-19 Vaccines\u2014Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.779453"},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"106233","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106233","article-title":"Repeated Cardioembolic Stroke after COVID-19 mRNA Vaccination: A Case Report","volume":"31","author":"Yoshida","year":"2022","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"101504","DOI":"10.1016\/j.eclinm.2022.101504","article-title":"Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A self-controlled case series study","volume":"50","author":"Chui","year":"2022","journal-title":"eClinicalMedicine"},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1111\/trf.16672","article-title":"Severe autoimmune hemolytic anemia following receipt of SARS-CoV-2 mRNA vaccine","volume":"61","author":"Gadi","year":"2021","journal-title":"Transfusion"},{"key":"ref_318","doi-asserted-by":"crossref","unstructured":"D\u2019agostino, V., Caranci, F., Negro, A., Piscitelli, V., Tuccillo, B., Fasano, F., Sirabella, G., Marano, I., Granata, V., and Grassi, R. (2021). A Rare Case of Cerebral Venous Thrombosis and Disseminated Intravascular Coagulation Temporally Associated to the COVID-19 Vaccine Administration. J. Pers. Med., 11.","DOI":"10.3390\/jpm11040285"},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"e17370","DOI":"10.1016\/j.heliyon.2023.e17370","article-title":"TTP-like syndrome and its relationship with complement activation in critically ill patients with COVID-19: A cross-sectional study","volume":"9","author":"Ardalan","year":"2023","journal-title":"Heliyon"},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1159\/000533339","article-title":"Immunothrombosis and Complement Activation Contribute to Disease Severity and Adverse Outcome in COVID-19","volume":"15","author":"Ruggeri","year":"2023","journal-title":"J. Innate Immun."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/ijpvm.ijpvm_192_21","article-title":"COVID-19, Vaccination, Multisystem Inflammatory Syndrome, Aneurysm, Screening and Post Vaccination Death","volume":"14","author":"Joob","year":"2023","journal-title":"Int. J. Prev. Med."},{"key":"ref_322","doi-asserted-by":"crossref","unstructured":"Afshar, Z.M., Pirzaman, A.T., Liang, J.J., Sharma, A., Pirzadeh, M., Babazadeh, A., Hashemi, E., Deravi, N., Abdi, S., and Allahgholipour, A. (2022). Do we miss rare adverse events induced by COVID-19 vaccination?. Front. Med., 9.","DOI":"10.3389\/fmed.2022.933914"},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"604","DOI":"10.12688\/f1000research.134171.1","article-title":"COVID-19 Vaccinations and Their Side Effects: A Scoping Systematic Review","volume":"12","author":"Monadhel","year":"2023","journal-title":"F1000Research"},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/CIRCULATIONAHA.123.067373","article-title":"RNA Therapeutics for the Cardiovascular System","volume":"149","author":"Dzau","year":"2024","journal-title":"Circulation"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10072-021-05662-9","article-title":"Spectrum of neurological complications following COVID-19 vaccination","volume":"43","author":"Garg","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2169\/internalmedicine.8967-21","article-title":"Sensory Ataxic Guillain-Barr\u00e9 Syndrome with Dysgeusia after mRNA COVID-19 Vaccination","volume":"61","author":"Ogata","year":"2022","journal-title":"Intern. Med."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"e228879","DOI":"10.1001\/jamanetworkopen.2022.8879","article-title":"Incidence of Guillain-Barr\u00e9 Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink","volume":"5","author":"Hanson","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/brain\/awac067","article-title":"COVID-19 vaccination and Guillain-Barr\u00e9 syndrome: Analyses using the National Immunoglobulin Database","volume":"146","author":"Keh","year":"2023","journal-title":"Brain"},{"key":"ref_329","doi-asserted-by":"crossref","unstructured":"Meo, S.A., Shaikh, N., Abukhalaf, F.A., and Meo, A.S. (2024). Exploring the adverse events of Oxford\u2013AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain\u2013Barr\u00e9 Syndrome. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-66999-7"},{"key":"ref_330","unstructured":"de Sa, K.S.G., Silva, J., Bayarri-Olmos, R., Brinda, R., Constable, R.A.R., Diaz, P.A.C., Kwon, D.-I., Rodrigues, G., Wenxue, L., and Baker, C. (2024). A Causal Link between Autoantibodies and Neurological Symptoms in Long COVID. medRxiv."},{"key":"ref_331","first-page":"1","article-title":"Guillain-Barr\u00e9 Syndrome Induced by Vaccination Against COVID-19: A Systematic Review and Meta-Analysis","volume":"15","author":"Ogunjimi","year":"2023","journal-title":"Cureus"},{"key":"ref_332","doi-asserted-by":"crossref","unstructured":"Ha, J., Park, S., Kang, H., Kyung, T., Kim, N., Kim, D.K., Kim, H., Bae, K., Song, M.C., and Lee, K.J. (2023). Real-world data on the incidence and risk of Guillain\u2013Barr\u00e9 syndrome following SARS-CoV-2 vaccination: A prospective surveillance study. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-30940-1"},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"e2253845","DOI":"10.1001\/jamanetworkopen.2022.53845","article-title":"Reports of Guillain-Barr\u00e9 Syndrome After COVID-19 Vaccination in the United States","volume":"6","author":"Abara","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s40001-023-00992-0","article-title":"A review of neurological side effects of COVID-19 vaccination","volume":"28","author":"Hosseini","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1016\/j.vaccine.2022.06.010","article-title":"Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform","volume":"40","author":"Walker","year":"2022","journal-title":"Vaccine"},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.therap.2021.03.005","article-title":"Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell\u2019s palsy","volume":"76","author":"Soeiro","year":"2021","journal-title":"Therapies"},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2024.01.099","article-title":"Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination\u2014A self-controlled case series analysis","volume":"42","author":"Morgan","year":"2024","journal-title":"Vaccine"},{"key":"ref_338","doi-asserted-by":"crossref","unstructured":"Poli, K., Poli, S., and Ziemann, U. (2022). Multiple Autoimmune Syndromes Including Acute Disseminated Encephalomyelitis, Myasthenia Gravis, and Thyroiditis Following Messenger Ribonucleic Acid-Based COVID-19 Vaccination: A Case Report. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.913515"},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s42466-021-00156-7","article-title":"A neurologist\u2019s rhombencephalitis after comirnaty vaccination. A change of perspective","volume":"3","author":"Walter","year":"2021","journal-title":"Neurol. Res. Pract."},{"key":"ref_340","first-page":"e144","article-title":"Seizures following COVID-19 vaccination in Mexico: A nationwide observational study","volume":"63","author":"Valencia","year":"2022","journal-title":"Epilepsia"},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"107952","DOI":"10.1016\/j.clineuro.2023.107952","article-title":"The COVID-19 pfizer BioNTech mRNA vaccine and the frequency of seizures","volume":"233","author":"Doron","year":"2023","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"107095","DOI":"10.1016\/j.ijid.2024.107095","article-title":"Association between COVID-19 vaccination and stroke: A nationwide case-control study in Qatar","volume":"145","author":"Chemaitelly","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jama.2024.1059","article-title":"Stroke Risk After COVID-19 Bivalent Vaccination Among US Older Adults","volume":"331","author":"Lu","year":"2024","journal-title":"JAMA"},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"e1465","DOI":"10.1212\/WNL.0000000000200996","article-title":"Acute Arterial Ischemic Stroke Following COVID-19 Vaccination: A Systematic Review and Meta-Analysis","volume":"99","author":"Stefanou","year":"2022","journal-title":"Neurology"},{"key":"ref_345","doi-asserted-by":"crossref","unstructured":"Filippatos, F., Tatsi, E.-B., and Michos, A. (2023). Immunology of Multisystem Inflammatory Syndrome after COVID-19 in Children: A Review of the Current Evidence. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065711"},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"e16209","DOI":"10.1111\/liv.16209","article-title":"Autoimmune-Like Hepatitis Related to SARS-CoV-2 Vaccination: Towards a Clearer Definition","volume":"45","author":"Efe","year":"2025","journal-title":"Liver Int."},{"key":"ref_347","doi-asserted-by":"crossref","unstructured":"Widhani, A., Hasibuan, A.S., Rismawati, R., Maria, S., Koesnoe, S., Hermanadi, M.I., Ophinni, Y., Yamada, C., Harimurti, K., and Sari, A.N.L. (2023). Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis. Vaccines, 11.","DOI":"10.3390\/vaccines11091456"},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2665-9913(23)00272-2","article-title":"Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: An emulated target trial","volume":"6","author":"Hanberg","year":"2024","journal-title":"Lancet Rheumatol."},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jaci.2024.01.025","article-title":"Autoimmune Adverse Event Following COVID-19 Vaccination in Seoul, South Korea","volume":"153","author":"Kim","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_350","doi-asserted-by":"crossref","unstructured":"Wu, P.-C., Huang, I.-H., Wang, C.-Y., and Chi, C.-C. (2024). New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review. Vaccines, 12.","DOI":"10.3390\/vaccines12050465"},{"key":"ref_351","first-page":"1421","article-title":"Multiple microthromboses with autoimmune hemolytic anemia after BNT162b2 mRNA vaccination","volume":"64","author":"Fujisaki","year":"2023","journal-title":"[Rinsho Ketsueki] Jpn. J. Clin. Hematol."},{"key":"ref_352","first-page":"106","article-title":"Probable warm autoimmune hemolytic anemia proceeding the administration of the Pfizer mRNA COVID-19 vaccine","volume":"38","author":"Nnawuba","year":"2022","journal-title":"Immunohematology"},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1515\/cclm-2022-0118","article-title":"Life-Threatening Autoimmune Hemolytic Anemia Fol-lowing mRNA COVID-19 Vaccination: Don\u2019t Be Too Prudent with the Red Gold","volume":"60","author":"Schauwvlieghe","year":"2022","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00277-021-04743-1","article-title":"Deep venous thrombosis and pulmonary embolism after COVID-19 mRNA vaccination","volume":"101","author":"Atoui","year":"2022","journal-title":"Ann. Hematol."},{"key":"ref_355","first-page":"390","article-title":"Subacute Thyroiditis Following SARS-CoV-2 Vaccination: An Autoimmune\/Inflammatory Syndrome Induced by Adjuvants (Asia Syndrome)","volume":"19","author":"Ciftel","year":"2023","journal-title":"Acta Endocrinol."},{"key":"ref_356","doi-asserted-by":"crossref","unstructured":"Alsudais, A.S., Alkanani, R.S., Fathi, A.B., Almuntashiri, S.S., Jamjoom, J.N., Alzhrani, M.A., Althubaiti, A., and Radi, S. (2023). Autoimmune diabetes mellitus after COVID-19 vaccination in adult population: A systematic review of case reports. BMC Endocr. Disord., 23.","DOI":"10.1186\/s12902-023-01424-0"},{"key":"ref_357","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.mayocp.2022.06.001","article-title":"SARS-CoV-2 mRNA Vaccination-induced Autoimmune Polyarthritis-like Rheumatoid Arthritis","volume":"97","author":"Abe","year":"2022","journal-title":"Mayo Clin. Proc."},{"key":"ref_358","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1111\/all.16231","article-title":"Elucidating allergic reaction mechanisms in response to SARS-CoV-2 mRNA vaccination in adults","volume":"79","author":"Shah","year":"2024","journal-title":"Allergy"},{"key":"ref_359","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jconrel.2023.06.027","article-title":"Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route","volume":"360","author":"Takata","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_360","doi-asserted-by":"crossref","first-page":"e2125524","DOI":"10.1001\/jamanetworkopen.2021.25524","article-title":"Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines with Confirmatory Testing in a US Regional Health System","volume":"4","author":"Warren","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_361","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11882-023-01065-2","article-title":"mRNA COVID-19 Vaccine Anaphylaxis: Epidemiology, Risk Factors, and Evaluation","volume":"23","author":"Jaggers","year":"2023","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_362","doi-asserted-by":"crossref","first-page":"103232","DOI":"10.1016\/j.autrev.2022.103232","article-title":"Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients","volume":"22","author":"Meroni","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"ref_363","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2169\/internalmedicine.1125-22","article-title":"IgG4-related Disease Emerging after COVID-19 mRNA Vaccination","volume":"62","author":"Aochi","year":"2023","journal-title":"Intern. Med."},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/s13256-024-04889-2","article-title":"Exponential decline, ceiling effect, downregulation, and T-cell response in immunoglobulin G antibody levels after messenger RNA vaccine boosters: A case report","volume":"18","author":"Hirano","year":"2024","journal-title":"J. Med. Case Rep."},{"key":"ref_365","first-page":"e847","article-title":"Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study","volume":"230","author":"Amstutz","year":"2024","journal-title":"J. Infect. Dis."},{"key":"ref_366","doi-asserted-by":"crossref","unstructured":"Qin, Z., Bouteau, A., Herbst, C., and Igy\u00e1rt\u00f3, B.Z. (2022). Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion. PLoS Pathog., 18.","DOI":"10.1101\/2022.03.16.484616"},{"key":"ref_367","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40123-021-00338-1","article-title":"Ophthalmological Considerations for COVID-19 Vaccination in Patients with Inflammatory Eye Diseases and Autoimmune Disorders","volume":"10","author":"Chau","year":"2021","journal-title":"Ophthalmol. Ther."},{"key":"ref_368","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1167\/iovs.64.14.37","article-title":"Neuro-Ophthalmic Adverse Events of COVID-19 Infection and Vaccines: A Nationwide Cohort Study","volume":"64","author":"Han","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_369","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1182\/blood.2021011958","article-title":"Prothrombotic immune thrombocytopenia after COVID-19 vaccination","volume":"138","author":"Tiede","year":"2021","journal-title":"Blood"},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"deac107.294","DOI":"10.1093\/humrep\/deac107.294","article-title":"P-308 Spontaneous reports of menstrual cycle disorders after mRNA COVID-19 vaccine","volume":"37","author":"Pietri","year":"2022","journal-title":"Hum. Reprod."},{"key":"ref_371","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/humrep\/deab238","article-title":"Effects of COVID-19 and mRNA vaccines on human fertility","volume":"37","author":"Chen","year":"2022","journal-title":"Hum. Reprod."},{"key":"ref_372","doi-asserted-by":"crossref","first-page":"e000743","DOI":"10.1136\/bmjmed-2023-000743","article-title":"Association between maternal mRNA COVID-19 vaccination in early pregnancy and major congenital anomalies in offspring: Population based cohort study with sibling matched analysis","volume":"3","author":"Jorgensen","year":"2024","journal-title":"BMJ Med."},{"key":"ref_373","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2022.4255","article-title":"Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes","volume":"327","author":"Fell","year":"2022","journal-title":"JAMA"},{"key":"ref_374","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jamapediatrics.2022.0164","article-title":"Association of COVID-19 Vaccination During Early Pregnancy With Risk of Congenital Fetal Anomalies","volume":"176","author":"Ruderman","year":"2022","journal-title":"JAMA Pediatr."},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"e2236609","DOI":"10.1001\/jamanetworkopen.2022.36609","article-title":"Association Between Time Interval from COVID-19 Vaccination to In Vitro Fertilization and Pregnancy Rate After Fresh Embryo Transfer","volume":"5","author":"Shi","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_376","doi-asserted-by":"crossref","first-page":"e28245","DOI":"10.1002\/jmv.28245","article-title":"Association of COVID-19 vaccination before conception with maternal thyroid function during early pregnancy: A single-center study in China","volume":"95","author":"Zhao","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_377","first-page":"354","article-title":"Myths Versus Facts: COVID-19 Vaccine Effects on Pregnancy, Fertility, and Menstruation","volume":"64","author":"Wong","year":"2022","journal-title":"Manag. Menopause New Guidel."},{"key":"ref_378","doi-asserted-by":"crossref","first-page":"460.e1","DOI":"10.1016\/j.ajog.2024.02.008","article-title":"Maternal vaccination against COVID-19 and neonatal outcomes during Omicron: INTERCOVID-2022 study","volume":"231","author":"Barros","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_379","first-page":"12","article-title":"Obstetric and Early Neonatal Outcomes Following Second and Third COVID-19 Vaccination in Pregnancy","volume":"26","author":"Gilboa","year":"2024","journal-title":"Isr. Med. Assoc. J. IMAJ"},{"key":"ref_380","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000538135","article-title":"Efficacy and Clinical Outcomes of mRNA COVID-19 Vaccine in Pregnancy: A Systematic Review and Meta-Analysis","volume":"67","author":"Santimano","year":"2024","journal-title":"Intervirology"},{"key":"ref_381","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/j.vaccine.2024.02.084","article-title":"Safety Monitoring of Bivalent mRNA COVID-19 Vaccine among Pregnant Persons in the Vaccine Adverse Event Reporting System\u2014United States, September 1, 2022\u2013March 31, 2023","volume":"42","author":"Moro","year":"2024","journal-title":"Vaccine"},{"key":"ref_382","doi-asserted-by":"crossref","first-page":"126506","DOI":"10.1016\/j.vaccine.2024.126506","article-title":"The risk of pregnancy-related adverse outcomes after COVID-19 vaccination: Propensity score-matched analysis with influenza vaccination","volume":"44","author":"Choi","year":"2025","journal-title":"Vaccine"},{"key":"ref_383","doi-asserted-by":"crossref","unstructured":"Ghanbari, E.P., Jakobs, K., Puccini, M., Reinshagen, L., Friebel, J., Haghikia, A., Kr\u00e4nkel, N., Landmesser, U., and Rauch-Kr\u00f6hnert, U. (2023). The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies. Biomedicines, 11.","DOI":"10.3390\/biomedicines11051371"},{"key":"ref_384","first-page":"1","article-title":"A Case of Autoimmune Hemolytic Anemia Following COVID-19 Messenger Ribonucleic Acid Vaccination","volume":"13","author":"Brito","year":"2021","journal-title":"Cureus"},{"key":"ref_385","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4103\/singaporemedj.SMJ-2021-157","article-title":"Localised swelling at sites of dermal filler injections following administration of COVID-19 vaccines: A systematic review","volume":"65","author":"Ng","year":"2024","journal-title":"Singap. Med. J."},{"key":"ref_386","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1089\/derm.2022.29003.msj","article-title":"Stevens\u2013Johnson Syndrome\/Toxic Epidermal Necrolysis Overlap After the Third Dose of BNT162b2 mRNA COVID-19 Vaccination and Literature Review","volume":"34","author":"Jue","year":"2023","journal-title":"Dermatitis\u00ae"},{"key":"ref_387","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10875-022-01408-0","article-title":"Macrophage Activation Syndrome Complicated by Toxic Epidermal Necrolysis Following SARS-CoV-2 mRNA Vaccination","volume":"43","author":"Franzblau","year":"2023","journal-title":"J. Clin. Immunol."},{"key":"ref_388","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s43678-022-00289-x","article-title":"Delayed Inflammatory Reaction to Dermal Fillers after COVID-19 Vaccination: A Case Report","volume":"24","author":"Beamish","year":"2022","journal-title":"Can. J. Emerg. Med."},{"key":"ref_389","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijid.2022.04.057","article-title":"An autopsy case of COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination","volume":"121","author":"Yoshimura","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_390","first-page":"1","article-title":"BCG Scar Local Skin Inflammation as a Novel Reaction Following mRNA COVID-19 Vaccines in Two International Healthcare Workers","volume":"13","year":"2021","journal-title":"Cureus"},{"key":"ref_391","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00228-022-03399-8","article-title":"Case series of chronic spontaneous urticaria following COVID-19 vaccines: An unusual skin manifestation","volume":"78","author":"Chahed","year":"2022","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_392","doi-asserted-by":"crossref","unstructured":"Grieco, T., Ambrosio, L., Trovato, F., Vitiello, M., Demofonte, I., Fanto, M., Paolino, G., and Pellacani, G. (2022). Effects of Vaccination against COVID-19 in Chronic Spontaneous and Inducible Urticaria (CSU\/CIU) Patients: A Monocentric Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11071822"},{"key":"ref_393","first-page":"e58740","article-title":"A Case Series of Rheumatoid Arthritis Flare Including Extra-Articular Manifestations Following SARS-CoV-2 mRNA Vaccination: A Compre-hensive Cytokine Assay","volume":"16","author":"Iwamura","year":"2024","journal-title":"Cureus"},{"key":"ref_394","first-page":"38","article-title":"Prevalence and factors associated with flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: A national cohort study","volume":"63","author":"Fong","year":"2023","journal-title":"Hortic. Bras."},{"key":"ref_395","doi-asserted-by":"crossref","first-page":"e29792","DOI":"10.1002\/jmv.29792","article-title":"Global burden of vaccine-associated hepatobiliary and gastrointestinal adverse drug reactions, 1967\u20132023: A comprehensive analysis of the international pharmacovigilance database","volume":"96","author":"Lee","year":"2024","journal-title":"J. Med. Virol."},{"key":"ref_396","doi-asserted-by":"crossref","first-page":"402","DOI":"10.5946\/ce.2023.268","article-title":"Polyposis of gastrointestinal tract after COVID-19 mRNA vaccination: A report of two cases","volume":"57","author":"Kim","year":"2024","journal-title":"Clin. Endosc."},{"key":"ref_397","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/ibd\/izad114","article-title":"Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study","volume":"30","author":"Mujukian","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_398","doi-asserted-by":"crossref","first-page":"100176","DOI":"10.1016\/j.jacig.2023.100176","article-title":"Gastrointestinal reflux contributes to laryngopharyngeal symptoms that mimic anaphylaxis: COVID-19 vaccination experience","volume":"3","author":"Kaplan","year":"2024","journal-title":"J. Allergy Clin. Immunol. Glob."},{"key":"ref_399","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jhep.2023.10.009","article-title":"Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients","volume":"80","author":"Murray","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_400","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12328-024-01926-x","article-title":"Severe ulcerative colitis induced by COVID-19 vaccination","volume":"17","author":"Taida","year":"2024","journal-title":"Clin. J. Gastroenterol."},{"key":"ref_401","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1136\/gutjnl-2021-326237","article-title":"Risk of adverse events and reported clinical relapse after COVID-19 vaccination in patients with IBD","volume":"71","author":"Cannatelli","year":"2022","journal-title":"Gut"},{"key":"ref_402","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13730-024-00945-4","article-title":"Acute tubulointerstitial nephritis following coronavirus disease 2019 mRNA vaccination: A pediatric case report","volume":"14","author":"Eguchi","year":"2024","journal-title":"CEN Case Rep."},{"key":"ref_403","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.xkme.2021.05.002","article-title":"IgA Nephropathy After SARS-CoV-2 Vaccination","volume":"3","author":"Abramson","year":"2021","journal-title":"Kidney Med."},{"key":"ref_404","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1007\/s00345-023-04481-1","article-title":"Urological Complications after COVID 19 Vaccine Ac-cording to Age, Sex and Manufacturer","volume":"41","author":"Shim","year":"2023","journal-title":"World J. Urol."},{"key":"ref_405","doi-asserted-by":"crossref","first-page":"sfae122","DOI":"10.1093\/ckj\/sfae122","article-title":"The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment","volume":"17","author":"Imhof","year":"2024","journal-title":"Clin. Kidney J."},{"key":"ref_406","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/tmi.13947","article-title":"Patterns and outcomes of late onset thyroid disturbances after COVID-19 vaccination: A report of 75 cases","volume":"29","author":"Kaur","year":"2024","journal-title":"Trop. Med. Int. Health"},{"key":"ref_407","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s40618-022-01786-7","article-title":"Thyroid dysfunction following vaccination with COVID-19 vaccines: A basic review of the preliminary evidence","volume":"45","author":"Jafarzadeh","year":"2022","journal-title":"J. Endocrinol. Investig."},{"key":"ref_408","doi-asserted-by":"crossref","first-page":"367","DOI":"10.14740\/jmc4307","article-title":"New Onset of Type 1 Diabetes Mellitus Post-COVID-19 Vaccine","volume":"15","author":"Aburisheh","year":"2024","journal-title":"J. Med. Cases"},{"key":"ref_409","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s12020-022-03169-7","article-title":"Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination","volume":"78","author":"Mungmunpuntipantip","year":"2022","journal-title":"Endocrine"},{"key":"ref_410","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12020-022-03130-8","article-title":"Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination","volume":"78","author":"Cesur","year":"2022","journal-title":"Endocrine"},{"key":"ref_411","doi-asserted-by":"crossref","unstructured":"Xiong, X., Lui, D.T.W., Chung, M.S.H., Au, I.C.H., Lai, F.T.T., Wan, E.Y.F., Chui, C.S.L., Li, X., Cheng, F.W.T., and Cheung, C.-L. (2023). Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study. PLoS Med., 20.","DOI":"10.1371\/journal.pmed.1004274"},{"key":"ref_412","doi-asserted-by":"crossref","first-page":"e2495","DOI":"10.1002\/rmv.2495","article-title":"Serological response and immune-related adverse events following COVID-19 vaccination in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis","volume":"34","author":"Wang","year":"2024","journal-title":"Rev. Med. Virol."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/10\/1327\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T04:12:31Z","timestamp":1760674351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/10\/1327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":412,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["pharmaceutics17101327"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics17101327","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]}}}